
<html lang="en"     class="pb-page"  data-request-id="5b55da1c-8ba4-4851-aba2-015621d694f8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2009.52.issue-20;article:article:10.1021/jm9004779;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression" /></meta><meta name="dc.Creator" content="Nicola M.  Aston" /></meta><meta name="dc.Creator" content="Paul  Bamborough" /></meta><meta name="dc.Creator" content="Jacqueline B.  Buckton" /></meta><meta name="dc.Creator" content="Christopher D.  Edwards" /></meta><meta name="dc.Creator" content="Duncan S.  Holmes" /></meta><meta name="dc.Creator" content="Katherine L.  Jones" /></meta><meta name="dc.Creator" content="Vipulkumar K.  Patel" /></meta><meta name="dc.Creator" content="Penny A.  Smee" /></meta><meta name="dc.Creator" content="Donald O.  Somers" /></meta><meta name="dc.Creator" content="Giovanni  Vitulli" /></meta><meta name="dc.Creator" content="Ann L.  Walker" /></meta><meta name="dc.Description" content="p38α MAP kinase is a key anti-inflammatory target for rheumatoid arthritis, influencing biosynthesis of pro-inflammatory cytokines TNFα and IL-1β at a translational and transcriptional level. In th..." /></meta><meta name="Description" content="p38α MAP kinase is a key anti-inflammatory target for rheumatoid arthritis, influencing biosynthesis of pro-inflammatory cytokines TNFα and IL-1β at a translational and transcriptional level. In th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 22, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9004779" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9004779" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9004779" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9004779" /></link>
        
    
    

<title>p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9004779" /></meta><meta property="og:title" content="p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0016.jpeg" /></meta><meta property="og:description" content="p38α MAP kinase is a key anti-inflammatory target for rheumatoid arthritis, influencing biosynthesis of pro-inflammatory cytokines TNFα and IL-1β at a translational and transcriptional level. In this paper, we describe how we have optimized a series of novel p38α/β inhibitors using crystal structures of our inhibitors bound to p38α, classical medicinal chemistry, and modeling of virtual libraries to derive a molecule suitable for progression into clinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9004779"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9004779">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9004779&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9004779&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9004779&amp;href=/doi/10.1021/jm9004779" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 6257-6269</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901031h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900647e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola+M.++Aston">Nicola M. Aston</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bamborough">Paul Bamborough</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline+B.++Buckton">Jacqueline B. Buckton</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+D.++Edwards">Christopher D. Edwards</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duncan+S.++Holmes">Duncan S. Holmes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+L.++Jones">Katherine L. Jones</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vipulkumar+K.++Patel">Vipulkumar K. Patel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Penny+A.++Smee">Penny A. Smee</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+O.++Somers">Donald O. Somers</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Vitulli">Giovanni Vitulli</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann+L.++Walker">Ann L. Walker</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 441 438 763 606. Fax: 441 438 763 616. E-mail: <a href="/cdn-cgi/l/email-protection#e0a18e8eceacceb7818c8b8592a0a7b3abce838f8d"><span class="__cf_email__" data-cfemail="ecad8282c2a0c2bb8d8087899eacabbfa7c28f8381">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9004779&amp;href=/doi/10.1021%2Fjm9004779" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 6257–6269</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 22, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 April 2009</li><li><span class="item_label"><b>Published</b> online</span>22 September 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 October 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9004779" title="DOI URL">https://doi.org/10.1021/jm9004779</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6257%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNicola%2BM.%2BAston%252C%2BPaul%2BBamborough%252C%2BJacqueline%2BB.%2BBuckton%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D20%26contentID%3Djm9004779%26title%3Dp38%25CE%25B1%2BMitogen-Activated%2BProtein%2BKinase%2BInhibitors%253A%2BOptimization%2Bof%2Ba%2BSeries%2Bof%2BBiphenylamides%2Bto%2BGive%2Ba%2BMolecule%2BSuitable%2Bfor%2BClinical%2BProgression%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6269%26publicationDate%3DOctober%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9004779"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2828</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9004779" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;M. Aston&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bamborough&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;B. Buckton&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;D. Edwards&quot;},{&quot;first_name&quot;:&quot;Duncan&quot;,&quot;last_name&quot;:&quot;S. Holmes&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;L. Jones&quot;},{&quot;first_name&quot;:&quot;Vipulkumar&quot;,&quot;last_name&quot;:&quot;K. Patel&quot;},{&quot;first_name&quot;:&quot;Penny&quot;,&quot;last_name&quot;:&quot;A. Smee&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;O. Somers&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Vitulli&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;L. Walker&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;6257-6269&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9004779&quot;},&quot;abstract&quot;:&quot;p38α MAP kinase is a key anti-inflammatory target for rheumatoid arthritis, influencing biosynthesis of pro-inflammatory cytokines TNFα and IL-1β at a translational and transcriptional level. In this paper, we describe how we have optimized a series of novel p38α/β inhibitors using crystal structures of our inhibitors bound to p38α, classical medicinal chemistry, and modeling of virtual libraries to derive a molecule suitable for progression into clinical development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9004779&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004779" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9004779&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004779" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9004779&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004779" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9004779&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9004779&amp;href=/doi/10.1021/jm9004779" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9004779" /></input><a href="/doi/pdf/10.1021/jm9004779" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9004779%26sid%3Dliteratum%253Aachs%26pmid%3D19772287%26genre%3Darticle%26aulast%3DAston%26date%3D2009%26atitle%3Dp38%25CE%25B1%2BMitogen-Activated%2BProtein%2BKinase%2BInhibitors%253A%2BOptimization%2Bof%2Ba%2BSeries%2Bof%2BBiphenylamides%2Bto%2BGive%2Ba%2BMolecule%2BSuitable%2Bfor%2BClinical%2BProgression%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D20%26spage%3D6257%26epage%3D6269%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">p38α MAP kinase is a key anti-inflammatory target for rheumatoid arthritis, influencing biosynthesis of pro-inflammatory cytokines TNFα and IL-1β at a translational and transcriptional level. In this paper, we describe how we have optimized a series of novel p38α/β inhibitors using crystal structures of our inhibitors bound to p38α, classical medicinal chemistry, and modeling of virtual libraries to derive a molecule suitable for progression into clinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Introduction of anticytokine biological therapies, for example, Etanercept, Infliximab, Adalimumab, and Anakinra, which specifically inhibit pro-inflammatory cytokines TNFα (tumor necrosis factor α<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: MAP, kinase mitogen-activated protein kinase; TNFα, tumour necrosis factor alpha; IL-1β, Interleukin 1 beta; RA, rheumatoid arthritis; DMARD, disease modifying antirheumatic drug; NSAID, nonsteroidal anti-inflammatory; PG-PS, peptidoglycan-polysaccharide; CIA, collagen induced arthritis; COPD, chronic obstructive pulmonary disease; PBMC, peripheral blood mononuclear cells; HWB, human whole blood; HSA, human serum albumin; LCMS, liquid chromatography−mass spectrometry.</p></div>) and IL-1β (interleukin-1β), have resulted in significant progress in the treatment of rheumatoid arthritis (RA) patients who do not respond to current nonsteroidal anti-inflammatories (NSAIDs) or current disease modifying antirheumatic drugs (DMARDs).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, the administration of these biological therapies by injection or infusion is burdensome to patients and physicians. An oral therapy, such as a new, small molecule therapy would be a more convenient administration form. The serine/threonine kinase p38α has been identified as a key anti-inflammatory target, involved in the production of both TNFα and IL-1β,<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> and many pharmaceutical companies have pursued p38α inhibitors as an anti-inflammatory therapy.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> To date, none of these molecules have progressed beyond clinical trials, as raised levels of liver enzymes associated with liver toxicity have been seen in some human trials and neurological effects in others.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Most of the earlier p38α inhibitors have relatively unselective kinase profiles or show inhibition of cytochrome p450 isoforms, either of which might be associated with the side effects seen in the clinic. In our earlier publications,<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> we described the optimization of a micromolar cross-screening hit to a small potent and selective p38α/β inhibitor <b>1</b> with an acceptable in vivo pharmacokinetic profile and activity in the rat peptidoglycan-polysaccharide reactivation (PG-PS)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and mouse collagen induced arthritis (CIA)<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15-18)</a> inflammation models. In this paper, we describe further optimization of <b>1</b>, by increasing potency in an assay to determine the inhibition of TNFα production in human whole blood (HWB) and improving the CYP450 profile resulting in a clinical candidate <b>2</b>, developed for treatment of rheumatoid arthritis (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This molecule is currently also being clinically evaluated for other inflammatory indications including chronic obstructive pulmonary disease (COPD) and heart disease.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0017.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead molecule <b>1</b> and clinical candidate <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b>, while selective for p38α/β and active in rat reactivation PG-PS (ED<sub>50</sub> 0.02 mg/kg) and murine CIA (in which it totally prevented the progression of arthritis at 15 mg/kg/day) models, is weakly active in the HWB assay of inhibition of TNFα release and displays some potential liabilities against p450 isoform 2C9 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Several potential causes of the low potency seen in the HWB assay have been considered; cellular penetration can only be a partial cause as the drop-off in activity from the enzyme to HWB is larger than that for the enzyme to the isolated human monocyte assay (PBMC). To try to understand this difference, a set of 48 compounds, from the biphenyl amide (BPA) and other chemical series, was profiled in PBMC and HWB assays using cells from the same donors. In addition, the physicochemical properties, CHI LogD (pH2, 7.4, 10.5),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> human serum albumin (HSA) binding,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and solubility<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> were measured and further parameters calculated. Statistical models were then generated on this data and tested by attempting to predict the drop-off for a further set of compounds. The models proved to be of limited predictive use, partially due to high interdonor variability for the cellular assays, and no unequivocal understanding was gained regarding factors affecting the relative PBMC and HWB potencies.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Additional Substituents at the 5- and 4-Positions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0018.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">R<sub>1</sub></th><th align="center">R<sub>2</sub></th><th align="center" char=".">p38α FP p<i>K</i><sub>i</sub> (n)</th><th align="center">PBMC pIC<sub>50</sub> (n)</th><th align="center">HWB pIC<sub>50</sub> (n)</th><th align="center">CYP450, 2C9, pIC<sub>50</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">H</td><td align="left">H</td><td align="char" char=".">7.9 (11)</td><td align="char">6.7 (24)</td><td align="char">5.8 (22)</td><td align="char">5.4</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">F</td><td align="left">H</td><td align="char" char=".">8.4 (6)</td><td align="char">7.0 (13)</td><td align="char">6.6 (12)</td><td align="char">5.7</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left">Cl</td><td align="left">H</td><td align="char" char=".">7.9 (2)</td><td align="char">6.8 (2)</td><td align="char">5.9 (2)</td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">Me</td><td align="left">H</td><td align="char" char=".">7.0 (1)</td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">H</td><td align="left">F</td><td align="char" char=".">6.9 (2)</td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="char">nd<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">nd, not determined.</p></div></div></div><div class="NLM_p">Comparison of crystal structures of <b>1</b> and a second series of in-house p38α inhibitors bound to p38α led to the introduction of a fluorine at the 5-position <b>3</b>, resulting in a 3-fold increase in p38α enzyme activity and a similar increase in PBMC potency but a 6-fold increase in HWB potency. Replacement of the fluorine by chlorine <b>4</b> gave no enhancement in potency in either the enzyme or cellular assays, and replacement by methyl <b>5</b> resulted in a 25-fold drop in enzyme potency. Shifting the fluorine to the 4-position <b>6</b>, which modeling had suggested would be equally valid, resulted in a 9-fold decrease in enzyme potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">These results can be explained by examination of a model of compound <b>3</b> bound to p38α, where it can be seen that the 5-substituent would bind in a lipophilic pocket formed by Leu 104 and Lys 53 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Fluorine appears to be optimal for the available space, with the larger chlorine and methyl groups causing unfavorable interactions due to the proximity to the protein. The lower affinity of <b>6</b> can also be explained by postulating that the 4-fluorine would be electrostatically unfavorable due to the close proximity of Glu71, approximately 2.2 Å by modeling.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>3</b> bound to p38α showing the fluorine binding in a small pocket formed by Leu 104 and Lys 53.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although <b>3</b> has improved HWB potency, it still has a potential cytochrome p450 liability at 2C9. To overcome this, a 2500-member virtual library was created, varying the 4′-amide. The amines had a wide variety of structural subtypes, as we knew from previous arrays that p38α has a wide tolerance in this area of the binding site.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> The amines were chosen on molecular weight and by avoidance of reactive groups, with no bias from the current preferred groups. To this library, series specific predictors for oral bioavailability (high oral absorption − ACDlogD < 4 and CMR < 12) and cytochrome p450 liability [negligible CYP2C9 inhibition − ACDlogD < 4 and ApK<i>a</i> > 10 (first acidic p<i>K</i><sub>a</sub>)], which had been generated from analysis of the SAR of previous examples of the series, were applied.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As the result of this, a set of cyclopropylmethyl replacements was chosen and further 87 analogues of <b>3</b> prepared. This resulted in a small set of molecules <b>7</b>−<b>10</b> with improved cytochrome p450 profiles and HWB pIC<sub>50</sub> > 6.5 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Results of the 4′-Amide Array Derived by a Virtual Array Process</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0002.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0003.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div></div><div class="NLM_p">In work ongoing in parallel, comparison of several p38α crystal structures generated for this series suggested that a network of water molecules fills part of the site close to the 2′-position of the 1,4-substituted phenyl ring. This offered the possibility of obtaining favorable or at least tolerated interactions with these water molecules by the introduction of heteroatoms.</div><div class="NLM_p">With this intention, a nitrogen was introduced into the 2′-position of the 1,4-substituted phenyl ring. The resulting compound <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) displayed a similar p38α enzyme potency (p<i>K</i><sub>i</sub> 7.6, <i>n</i> = 9) to the phenyl analogue <b>1</b> (p<i>K</i><sub>i</sub> 7.9) and had a moderate potency in the HWB assay (pIC<sub>50</sub> 6.5, <i>n</i> = 3). A crystal structure of <b>11</b> bound to p38α (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) clearly shows the interaction of the pyridine with the conserved water network. Compared with <b>3</b>, Tyr35 (not visible in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) has moved from a position packed across the front of the inhibitor to allow the pyridine nitrogen access to the water network, however this change appears to have little effect on p38α potency.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>11</b> bound to p38α showing interaction of pyridine with network of conserved water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures <b>11</b>−<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>11</b> has an excellent rat DMPK profile, with oral bioavailability of 99%, low clearance (1.5 mL/mg/kg), and a long half-life (iv <i>T</i><sub>1/2</sub> 3.0 h); additionally, the cytochrome p450 profile was improved over its phenyl analogue (2C9 pIC<sub>50</sub> 4.4, 1A2, 2C19, 2D6, 3A4 pIC<sub>50</sub> <4). The isomeric pyridine with the nitrogen inserted into the 3′-position of <b>12</b> was prepared for comparison, and <b>12</b> shows substantially lower p38α potency (pKi 6.1, <i>n</i> = 3), which is surprising given that the pyridine in this position might be expected to help to rigidify the structure by forming an internal hydrogen bond to the NH of the amide.</div><div class="NLM_p">The 5-fluorine used to enhance HWB potency in the biphenyl series was introduced into the 2′-pyridyl series. The resulting compound, <b>13</b>, combines HWB potency (pIC<sub>50</sub> 7.1, <i>n</i> = 11) and a clean cytochrome p450 profile (pIC<sub>50</sub> < 4.2 at all isoforms). p38α and p38β were inhibited with p<i>K</i><sub>i</sub>’s of 8.1 and 7.6, respectively, and at least 100-fold selectivity was maintained against a panel of 33 kinases, including AKT1, ALK5, CDK2, EGFR, ErbB2, GSK3β, IKK2, IKK-ε, JNK3, LCK, PDGFR1B, PLK1, ROCK1, SRC, TIE2, and VEGFR2. The excellent oral bioavailability seen for <b>11</b> was maintained in the 5-<i>F</i> analogue (<i>F</i> > 95%, Clr 2.5 mL/min/kg, iv <i>T</i><sub>1/2</sub> 1.9 h).</div><div class="NLM_p">Reoptimization of the cyclopropylmethylamide moiety of <b>13</b>, by preparation of ca. 180 amides chosen as close analogues and also by the virtual library process described earlier, identified several further compounds that have increased potency and good cytochrome p450 profiles. The most interesting of these were ranked by oral AUC in rat cassette DMPK studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The additional α-methyl group on the amine in <b>15</b>, <b>16</b>, and <b>18</b> had a dramatic effect on the exposure, reducing the oral AUC from 360 ng·h/mL for isobutyl amide <b>14</b> to 8 ng·h/mL and 50 ng·h/mL, respectively, for the α-methylated enantiomers <b>15</b> and <b>16</b> (0.25 mg/kg dose). No further in vivo DMPK studies were performed on <b>15</b> and <b>16</b>, as the lower oral exposure was consistent with the in vitro clearance data generated in rat liver microsomes.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Results of 4-Amide Arrays in the Pyridine Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0006.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0007.gif" alt="" id="fx5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">nd, not determined.</p></div></div></div><div class="NLM_p">Compounds <b>13</b>, <b>14</b>, and <b>2</b> were profiled in the rat PG-PS reactivation model of arthritis; compound <b>14</b> generated a poor dose response curve and no ED<sub>50</sub> was calculated, but <b>13</b> and <b>2</b> gave ED<sub>50</sub>s of 0.1 mg/kg and 0.03 mg/kg, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The rationale for the poor dose response for <b>14</b> in the PG-PS model is unclear, as the cassette DMPK profiles of <b>2</b> and <b>14</b> are very similar (<b>2</b>: Clr 9.2 mL/min/kg, iv <i>T</i><sub>1/2</sub> 1.1 h, <i>F</i> 51%; <b>14</b>: Clr 6.4 mL/min/kg, iv <i>T</i><sub>1/2</sub> 1.1 h, <i>F</i> 56%. Dosed at 0.25 mg/kg po and iv).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compounds <b>2</b> and <b>13</b> dosed orally twice daily on inflammation in the PG-PS reactivation arthritis model assessed by reduction in measured ankle swelling (mm). A comparison with prednisolone dosed at 2.0 mg/kg once daily is shown. * = <i>p</i> < 0.05 (Anova with posthoc planned comparisons, treatment vs control). ** = <i>p</i> < 0.01 (Anova with posthoc planned comparisons, treatment vs control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>2</b> on pain in the PG-PS reactivation arthritis model assessed by weight bearing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>2</b> also demonstrated an analgesic effect in the rat PG-PS model, shown by increasing weight bearing on the injected paw on days 1 through 3 of the study, giving results equivalent to prednisolone (2 mg/kg) at a dose of 0.3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><div class="NLM_p">In the murine CIA model, <b>2</b> showed dose related anti-inflammatory and joint protective activity, reducing clinical score, cellular influx into the synovial tissue and joint space, cartilage destruction, and new bone formation. At 20 mg/kg po bid, there was complete suppression of arthritis (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibition of clinical score in the murine CIA model following 14 days of dosing with <b>2</b> (po bid), compared with prednisolone (3 mg/kg po once daily). * = <i>p</i> < 0.05 (Anova with posthoc planned comparisons, treatment vs control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Further studies on compound <b>2</b> confirmed that, as well as being competitive with the fluorescent ATP-site ligand used to generate the SAR reported here, <b>2</b> was competitive with ATP in an assay measuring the catalytic activity of activated p38α with a <i>K</i><sub>i</sub> of 7.2. Compound <b>2</b> was profiled against a panel of 67 human kinases, using both in-house (pIC<sub>50</sub> and % inhibition) and Dundee panel (% inhibition) screening. No significant inhibition of these kinases including AKT1, ALK5, CDK2, EGFR, ErbB2, GSK3β, IKK2, IKK-ε, JNK3, LCK, PDGFR1B, PLK1, ROCK1, SRC, TIE2, and VEGFR2 was seen, and <b>2</b> has been shown to be highly selective for p38α/β. Compound <b>2</b> has an excellent p450 profile (pIC<sub>50</sub> 2C9 4.5, 1A2, 2C19, 2D6, 3A4 ≤4.1) and moderate binding to rat and human serum albumen (96.0 and 94.9%, respectively). Compound <b>2</b> has acceptable pharmacokinetics in four species, rat (discrete data at 1 mg/kg po and iv: <i>F</i> 71%, iv <i>T</i><sub>1/2</sub> 1.2 h, Clr 8.1 mL/mg/kg. and Vdss 0.9 mg/L), mouse (F 59%), dog (F 55%), and cynomolgus monkey (F 35%), with a desirably low level of brain exposure seen in the rat studies (brain:plasma ratio 0.1).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Using a combination of crystal structures of the biphenylamides bound to p38α, classical medicinal chemistry, array, and virtual array techniques, the BPA series has been optimized from an initial low potency cross-screening hit,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> via a compound with high enzyme potency but suboptimal properties <b>1</b>, to a molecule suitable for clinical development <b>2</b>. This molecule has been developed for treatment of rheumatoid arthritis and is also currently being clinically evaluated for indications including COPD and heart disease</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Chemistry</h3><div class="NLM_p">One of the advantages of the biphenylamide series of p38α inhibitors is their straightforward and flexible synthesis, either of the amide groups may be inserted in the final step or both amides may be prepared, and the biphenyl formed by a final Suzuki reaction (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Biphenylamide Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> has been synthesized by a number of routes, one of which (route B) has previously been described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Compounds <b>3</b>−<b>6</b> were prepared by route C, requiring the trisubstituted benzoic acids <b>19a</b>−<b>d</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). These were not available commercially, so they were synthesized by bromination of the disubstituted acids using bromine and iron powder. While this preparation is useable on a small scale, where there was a moderate and controllable exotherm, scale-up of <b>19a</b> required cooling due to a rapid temperature rise partway through the portionwise addition of the acid to the iron/bromine mixture. The resulting product contained two regioisomers, as had been seen in the small scale reaction, and also dibrominated material.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Compounds <b>3</b>−<b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) Br<sub>2</sub>, Fe powder, rt (exothermic); (ii) SOCl<sub>2</sub>, reflux; (iii) cyclopropylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM, rt; (iv) cyclopropylmethylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM, rt; (v) bispinnacolatodiboran, Pd(dppf)Cl<sub>2</sub>, KOAc, DMF, 80 °C; (vi) (Ph<sub>3</sub>P)<sub>4</sub>Pd, 1 M NaHCO<sub>3</sub>, IPA, 80 °C.</p></p></figure><div class="NLM_p">The 87 array compounds identified during the virtual array process were prepared by either route C, <b>7</b>, or by route A, which allowed facile variation of the 4′-amide, <b>8</b>−<b>10</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). To facilitate the larger arrays of amides, we wished to develop an improved synthesis of <b>20a</b> or preferably the equivalent iodide <b>23a</b>, giving greater control of the halogenation reaction and improved regioselectivity. The bromination with iron and bromine was repeated at lower temperatures (0−30 °C), but these conditions gave little reaction. Various iodination conditions were assessed; iodine with concentrated nitric and sulfuric acid gave a controllable reaction but produced a mixture of isomers, and greatest regioselectivity was found with <i>n</i>-iodosuccinimide in trifluoromethylsulfonic acid. On a small scale, this chemistry was performed at 0 °C to give only the desired isomer and uniodinated material, but for generating larger quantities of material, reaction at −20 °C was found to give improved control of regioselectivity.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. 4-Amide Array Chemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) NIS, trifluoromethylsulfonic acid, −20 °C; (ii) SOCl<sub>2</sub> then cyclopropylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM; (iii) {4-[(methyloxy)carbonyl]phenyl}boronic acid, (Ph<sub>3</sub>P)<sub>4</sub>Pd, 1 M NaHCO<sub>3</sub>, IPA, 80 °C; (iv) 2 M NaOH, MeOH; (v) RNH<sub>2</sub>, HATU, DIPEA, DMF/DCM, rt.</p></p></figure><div class="NLM_p">To avoid the toxicity issues associated with stannane chemistry for introduction of the 2′-pyridine, 3′-pyridine, and 2,6-pyrimidine, we desired the boronate esters <b>25a</b>−<b>b</b> or the equivalent boronic acid <b>26a</b>. These were readily prepared from the iodides, either by palladium chemistry or by lithiation and reaction with triisopropyl borate (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Fluorinated Boronate Ester/Boronic Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) bispinnacolatodiboran, Pd(dppf)Cl<sub>2</sub>, KOAc, DMF, 80 °C; (ii) NaH, <i>n</i>-BuLi, (iPrO)<sub>3</sub>B, THF, −75 °C.</p></p></figure><div class="NLM_p">The pyridines were then, simply prepared by Suzuki reaction of the boronate with an appropriate halopyridine (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Pyridine Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) SOCl<sub>2</sub> 80 °C; (ii) cyclopropylmethylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM rt; (iii) <b>25b</b>, (Ph<sub>3</sub>P)<sub>4</sub>Pd, 1 M NaHCO<sub>3</sub>, DMF, 90 °C.</p></p></figure><div class="NLM_p last">Pyridines <b>2</b> and <b>13</b>−<b>18</b> were prepared in a similar fashion from <b>25a</b> or <b>26a</b> and the appropriate chloronicotinamide.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Experimental Details</h3><div class="NLM_p last">All commercial reagents and solvents were obtained from commercial sources and used without further purification. Unless otherwise specified, all reactions were performed under nitrogen. LCMS was conducted on a Supelcosil LCABZ+PLUS column (3.3 cm × 4.6 mm ID) eluting with 0.1% HCO<sub>2</sub>H and 0.01 M ammonium acetate in water (solvent A) and 0.05% HCO<sub>2</sub>H 5% water in acetonitrile (solvent B), using the following elution gradient 0.0−0.7 0% B, 0.7−4.2 min 0−100% B, 4.2−4.6 min 100% B, 4.6−4.8 min 100−0% B at a flow rate of 3 mL/min. The mass spectra were recorded on a Waters ZQ mass spectrometer using electrospray positive and negative mode (ES+ve and ES−ve). Unless otherwise specified, <sup>1</sup>H NMR spectra were recorded using a 400 MHz spectrometer and chemical shifts are given in ppm (δ) relative to tetramethylsilane (TMS) as an internal standard. Purity of the tested compounds was of >95% using interpretation of a combination of LCMS and NMR data unless stated otherwise.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>N</i><sup>3</sup>-Cyclopropyl-<i>N</i><sup>4</sup>′-(cyclopropylmethyl)-5-fluoro-6-methyl-3,4′-biphenyldicarboxamide (<b>3</b>)</h3><div class="NLM_p last">3-Bromo-<i>N</i>-cyclopropyl-5-fluoro-4-methylbenzamide (<b>20a</b>, 90 mg, 0.34 mmol), <i>N</i>-cyclopropylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide (<b>22</b>, 95 mg, 0.32 mmol), and tetrakis(triphenylphosphine)palladium (6.0 mg, 5.2 × 10<sup>−3</sup> mmol) and aq sodium hydrogen carbonate (1M, 1.5 mL) were mixed in propan-2-ol (6 mL). The mixture was heated at 90 °C for 18 h. The cooled reaction was adsorbed onto silica under vacuum, and the residue was purified by chromatography on a silica cartridge (10 g) eluting with an ethyl acetate/cyclohexane gradient (0−75%). Appropriate fractions were reduced to dryness under vacuum and the residue triturated with diethyl ether to give the desired product (70 mg, 60%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.65 (t, <i>J</i> = 5.5 Hz, 1H), 8.53 (d, <i>J</i> = 4.0 Hz, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 2H), 7.64 (d, <i>J</i> = 11.0 Hz, 1H), 7.60 (1H, s), 7.49 (d, <i>J</i> = 8.0 Hz, 2H), 3.18 (t, <i>J</i> = 6.0 Hz, 2H), 2.85 (1H, m), 2.17 (d, <i>J</i> = 2.0 Hz, 3H), 1.05 (1H, m), 0.70 (2H, m), 0.57 (2H, m), 0.45 (2H, m), 0.25 (2H, m). LCMS: MH<sup>+</sup> 367, retention time 3.06 min. Anal. Calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>2</sub>·0.4H<sub>2</sub>O: C, 70.72; H, 6.42; N, 7.50. Found: C, 70.85; H, 6.19; N, 7.25.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 3-Bromo-<i>N</i>-cyclopropyl-5-fluoro-4-methylbenzamide (<b>20a</b>)</h3><div class="NLM_p last">3-Fluoro-4-methylbenzoic acid (460 mg, 3.0 mmol) was added to a stirred mixture of bromine (2.3 mL, 45 mmol) and iron powder (250 mg, 4.5 mmol) under nitrogen. The reaction was stirred at 20 °C for 4 h and then left to stand for 16 h. Sodium thiosulfate solution (200 mL) was added, and the product was extracted into ethyl acetate (3 × 150 mL). Ethyl acetate extracts were combined and evaporated under vacuum. The crude product (<b>19a</b>, mixture of isomers) was dissolved in DMF (7 mL). Cyclopropylamine (0.21 mL, 3.0 mmol), HOBT (410 mg, 3.0 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (580 mg, 3.0 mmol), and DIPEA (530 μL, 3.0 mmol) were added to the stirred solution. The reaction was stirred for 5 h at 20 °C. The solvent was evaporated under vacuum, and the residue was partitioned between ethyl acetate and water. The combined ethyl acetate extracts were washed sequentially with aq sodium hydrogen carbonate and hydrochloric acid (0.5M) and then dried (magnesium sulfate). The ethyl acetate was evaporated under vacuum, and the residue was purified by chromatography on a silica cartridge eluting with cyclohexane/ethyl acetate (6:1) to give the desired product (360 mg, 44%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.68 (s, 1H,), 7.39 (d, <i>J</i> = 9.5 Hz, 1H), 6.19 (bs, 1H), 2.88 (m, 1H), 2.36 (d, <i>J</i> = 2.5 Hz, 3H), 0.88 (m, 2H), 0.63 (m, 2H). LCMS: MH<sup>+</sup> 272/274, retention time 3.12 min. [When this reaction was repeated on 10 times the scale, with portionwise addition of the 3-fluoro-4-methylbenzoic acid (4.6 g, 30 mmol) to the iron/bromine mixture, ice cooling of the reaction was required part way through the addition due to a rapid exotherm.]</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>N</i>-Cyclopropylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide (<b>22</b>)</h3><div class="NLM_p last"><i>N</i>-(Cyclopropylmethyl)-4-iodobenzamide (<b>21</b>, 800 mg, 2.7 mmol), bispinnacolatodiboron (740 mg, 2.9 mmol), potassium acetate (1.2 g, 12 mmol), and Pd(dppf)Cl<sub>2</sub> (50 mg, 0.07 mmol) were mixed in DMF (10 mL) and heated at 80 °C overnight. The cooled reaction was adsorbed onto silica and purified by chromatography on a silica cartridge (10 g), eluting with an ethyl acetate/cyclohexane gradient (0−100%). The appropriate fractions were reduced to dryness under vacuum and the residue triturated with diethyl ether to give the desired product as a white solid (550 mg, 69%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.63 (t, <i>J</i> = 5.7 Hz, 1H), 7.85 (d, <i>J</i> = 8.5 Hz, 2H), 7.73 (d, <i>J</i> = 8.0 Hz, 2H), 3.13 (t, <i>J</i> = 6.3 Hz, 2H), 1.30 (s, 12H), 1.04 (m, 1H), 0.41 (m, 2H), 0.22 (m, 2H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-(Cyclopropylmethyl)-4-iodobenzamide (<b>21</b>)</h3><div class="NLM_p last">4-Iodobenzoic acid (1.0 g, 4.0 mmol) in thionyl chloride (3.0 mL, 41 mmol) was heated at 100 °C for 30 min. The excess thionyl chloride was evaporated under vacuum and the residue dissolved in DCM (10 mL). Cyclopropylmethylamine (0.35 mL, 4.0 mmol) and sodium carbonate (2.0 g, 19 mmol) were added to the solution and the reaction left at ambient temperature for 2 h. The reaction was filtered, the residue washed with DCM, and the combined filtrate and washings reduced to dryness under vacuum. The resulting material was triturated with diethyl ether to give the desired product as a white solid (850 mg, 71%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.61 (t, <i>J</i> = 5.5 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 2H), 7.62 (d, <i>J</i> = 8.5 Hz, 2H), 3.11 (t, <i>J</i> = 6.5 Hz, 2H), 1.00 (m, 1H), 0.41 (m, 2H), 0.21 (m, 2H). LCMS: MH<sup>+</sup> 302, retention time 2.98 min.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-Chloro-<i>N</i><sup><i>3</i></sup>-cyclopropyl-<i>N</i><sup><i>4</i></sup>′-(cyclopropylmethyl)-6-methyl-3,4′-biphenyldicarboxamide (<b>4</b>)</h3><div class="NLM_p last">3-Bromo-5-chloro-<i>N</i>-cyclopropyl-4-methylbenzamide (<b>20b</b>, 30 mg, 2:1 mixture with 3-chloro-<i>N</i>-cyclopropyl-4-methylbenzamide), <i>N</i>-cyclopropylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide (<b>22</b>, 28 mg, 0.09 mmol), tetrakis(triphenylphosphine)palladium (1.0 mg, 0.87 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (1M, 0.5 mL) were mixed in propan-2-ol (2 mL) and heated at 90 °C under nitrogen for 24 h. The reaction was adsorbed onto silica under vacuum, the residue purified by chromatography on a silica cartridge (5 g) eluting with an ethyl acetate/cyclohexane gradient (0−100%). The product fractions were reduced to dryness under vacuum and the residue recrystallized from ethyl acetate to give the desired product as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.65 (t, <i>J</i> = 5.5 Hz), 1H), 8.57 (d, <i>J</i> = 4.5 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 7.93 (d, <i>J</i> = 1.5 Hz, 1H), 7.68 (d, <i>J</i> = 1.5 Hz, 1H), 7.48 (d, <i>J</i> = 8.5 Hz, 2H), 3.18 (t, <i>J</i> = 6.0 Hz, 2H), 2.86 (m, 1H), 2.27 (s, 3H), 1.05 (m, 1H), 0.69 (m, 2H), 0.57 (m, 2H), 0.45 (m, 2H), 0.25 (m, 2H). LCMS: MH<sup>+</sup> 383/385, retention time 3.27 min.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-Bromo-5-chloro-<i>N</i>-cyclopropyl-4-methylbenzamide (<b>20b</b>)</h3><div class="NLM_p last">3-Bromo-5-chloro-4-methylbenzoic acid (<b>19b</b>, 310 mg, 2:1 mixture with 3-chloro-4-methylbenzoic acid) was mixed with thionyl chloride (3.0 mL, 41 mmol) and the mixture heated at 90 °C for 2.5 h. The excess thionyl chloride was evaporated under vacuum, and the residue was dissolved in DCM (7.5 mL). Cyclopropylamine (0.20 mL, 2.9 mmol) and sodium carbonate (∼500 mg) were added to the solution and the reaction stirred for 2 h at room temperature. The reaction was filtered, the residue washed with DCM, and the combined filtrate and washings were reduced to dryness under vacuum and the resulting solid triturated with cyclohexane. The resulting white solid was adsorbed onto silica under vacuum and purified by chromatography on a silica cartridge (10 g), eluting with an ethyl acetate/cyclohexane gradient (0−50%). The product fractions were reduced to dryness under vacuum to give a mixture of 3-bromo-5-chloro-<i>N</i>-cyclopropyl-4-methylbenzamide and 3-chloro-<i>N</i>-cyclopropyl-4-methylbenzamide (2:1). 3-Bromo-5-chloro-<i>N</i>-cyclopropyl-4-methylbenzamide <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.61 (d, <i>J</i> = 3.5 Hz 1H), 8.03 (s, 1H), 7.90 (s, 1H), 2.85 (m, 1H), 2.49 (s, 3H), 0.70 (m, 2H), 0.58 (m, 2H). LCMS: MH<sup>+</sup> 288/290/292, retention time 3.28 min.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-Bromo-5-chloro-4-methylbenzoic acid (<b>19b</b>)</h3><div class="NLM_p last">3-Chloro-4-methylbenzoic acid (270 mg, 1.6 mmol) was added in portions to a mixture of bromine (1.0 mL, 20 mmol) and iron powder (45 mg, 0.81 mmol) and the reaction stirred in a sealed vial for 28 h. The reaction mixture was poured into aq sodium thiosulfate and extracted with ethyl acetate. The combined extracts were washed with brine, dried (magnesium sulfate), and the solvent evaporated under vacuum. The residue was redissolved in ethyl acetate, filtered, and the filtrate reduced to dryness under vacuum to give a mixture of 3-bromo-5-chloro-4-methylbenzoic acid and 3-chloro-4-methylbenzoic acid (320 mg, 2:1). 3-Bromo-5-chloro-4-methylbenzoic acid <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.02 (d, <i>J</i> = 1.5 Hz, 1H), 7.89 (d, <i>J</i> = 1.5 Hz, 1H), 2.51 (s, 3H). LCMS: [M − H]<sup>−</sup> 247/249/251, retention time 3.73 min.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i><sup>3</sup>-Cyclopropyl-<i>N</i><sup>4</sup>′-(cyclopropylmethyl)-5,6-dimethyl-3,4′-biphenyldicarboxamide (<b>5</b>)</h3><div class="NLM_p last">3-Bromo-<i>N</i>-cyclopropyl-4,5-dimethylbenzamide (<b>20c</b>, 30 mg, 0.11 mmol), <i>N</i>-cyclopropylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide (<b>22</b>, 28 mg, 0.09 mmol), tetrakis(triphenylphosphine)palladium (1.0 mg, 0.87 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (1M, 0.5 mL) were mixed in propan-2-ol (2 mL) and heated at 90 °C under nitrogen for 24 h. The reaction was adsorbed onto silica under vacuum, and the residue was purified by chromatography on a silica cartridge (10 g) and eluted with an ethyl acetate/cyclohexane gradient (0−100% ethyl acetate). The product fractions were reduced to dryness under vacuum, and the residue was recrystallized from ethyl acetate to give the desired product as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.62 (t, <i>J</i> = 5.5 Hz, 1H), 8.38 (d, <i>J</i> = 4.0 Hz, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 2H), 7.67 (s, 1H), 7.52 (s, 1H), 7.41 (d, <i>J</i> = 8.5 Hz, 2H), 3.18 (t, <i>J</i> = 6.0 Hz, 2H), 2.84 (m, 1H), 2.34 (s, 3H), 2.14 (s, 3H), 1.05 (m, 1H), 0.68 (m, 2H), 0.56 (m, 2H), 0.45 (m, 2H), 0.25 (m, 2H). LCMS: MH<sup>+</sup> 363, retention time 3.06 min.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-Bromo-<i>N</i>-cyclopropyl-4,5-dimethylbenzamide (<b>20c</b>)</h3><div class="NLM_p last">3-Bromo-4,5-dimethylbenzoic acid<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<b>19c</b>, 200 mg, 0.87 mmol) was mixed with thionyl chloride (2.0 mL, 27 mmol) and the mixture heated at 90 °C for 2.5 h. The excess thionyl chloride was evaporated under vacuum, and the residue was dissolved in DCM (5 mL). Cyclopropylamine (0.2 mL, 2.9 mmol) and sodium carbonate (∼300 mg) were added to the solution and the reaction stirred for 2 h at room temperature. The reaction was filtered, the filtrate reduced to dryness under vacuum, and the residue triturated with diethyl ether. The resulting solid was dissolved in acetone/methanol and adsorbed onto silica under vacuum. The residue was purified by chromatography on a silica cartridge (5 g) eluting with an ethyl acetate/cyclohexane gradient (0−50% ethyl acetate) to give the desired product. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.44 (d, <i>J</i> = 4.0 Hz, 1H), 7.87 (s, 1H), 7.64 (s, 1H), 2.83 (m, 1H), 2.34 (s, 6H), 0.69 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 268/270, retention time 3.05 min.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i><sup>3</sup>-cyclopropyl-<i>N</i><sup>4</sup>′-(cyclopropylmethyl)-4-fluoro-6-methyl-3,4′-biphenyldicarboxamide (<b>6</b>)</h3><div class="NLM_p last">5-Bromo-<i>N</i>-cyclopropyl-2-fluoro-4-methylbenzamide (<b>20d</b>, 30 mg, 0.11 mmol), <i>N</i>-cyclopropylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzamide (<b>22</b>, 28 mg, 0.09 mmol), tetrakis(triphenylphosphine)palladium (1.0 mg, 0.87 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (1M, 0.5 mL) were mixed in propan-2-ol (2 mL) and heated at 90 °C under nitrogen for 24 h. The reaction was adsorbed onto silica under vacuum, and the residue was purified by chromatography on a silica cartridge (5 g) eluting with an ethyl acetate/cyclohexane gradient (0−100% ethyl acetate). The product fractions were reduced to dryness under vacuum and the residue recrystallized from ethyl acetate to give the desired product as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.63 (t, <i>J</i> = 6.0 Hz, 1H), 8.35 (d, <i>J</i> = 4.0 Hz, 1H), 7.93 (d, <i>J</i> = 8.0 Hz, 2H), 7.45 (d, <i>J</i> = 8.5 Hz, 2H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.27 (d, <i>J</i> = 11.5 Hz, 1H), 3.17 (t, <i>J</i> = 6.5 Hz, 2H), 2.83 (m, 1H), 2.26 (s, 3H), 1.05 (m, 1H), 0.69 (m, 2H), 0.54 (m, 2H), 0.45 (m, 2H), 0.25 (m, 2H). LCMS: MH<sup>+</sup> 367, retention time 2.97 min.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5-Bromo-<i>N</i>-cyclopropyl-2-fluoro-4-methylbenzamide (<b>20d</b>)</h3><div class="NLM_p last">5-Bromo-2-fluoro-4-methylbenzoic acid (<b>19d</b>, 180 mg, 0.77 mmol) was mixed with thionyl chloride (2.0 mL, 27 mmol) and the mixture heated at 90 °C for 2 h. The excess thionyl chloride was evaporated under vacuum, and the residue was dissolved in DCM (5 mL). Cyclopropylamine (0.10 mL, 1.4 mmol) and sodium carbonate (∼300 mg) were added to the solution and the reaction stirred for 2 h at room temperature. The reaction was filtered, the residue washed with DCM, and the combined filtrate and washings reduced to dryness under vacuum. The residue was recrystallized from cyclohexane to give the desired product as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.41 (s, 1H), 7.71 (d, <i>J</i> = 6.8 Hz, 1H), 7.36 (d, <i>J</i> = 10.8 Hz, 1H), 2.81 (m, 1H), 2.36 (s, 3H), 0.69 (m, 2H), 0.55 (m, 2H). LCMS: MH<sup>+</sup> 272/274, retention time 2.88 min.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-Bromo-2-fluoro-4-methylbenzoic Acid (<b>19d</b>)</h3><div class="NLM_p last">2-Fluoro-4-methylbenzoic acid<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (240 mg, 1.6 mmol) was added in portions to a mixture of bromine (1.0 mL, 20 mmol) and iron powder (60 mg, 1.1 mmol) and the reaction stirred in a sealed reacti-vial at room temperature for 25 min. The reaction was poured into aq sodium thiosulfate and extracted with ethyl acetate (×2). The combined extracts were washed with brine, dried (magnesium sulfate), and the solvent evaporated under vacuum. The residue was recrystallized from cyclohexane to give the desired product as a white solid (180 mg, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.44 (bs, 1H), 7.98 (d, <i>J</i> = 7.0 Hz, 1H), 7.41 (d, <i>J</i> = 11.5 Hz, 1H), 2.39 (s, 3H). LCMS: [M − H]<sup>−</sup> 231/233, retention time 3.37 min.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i><sup>3</sup>-Cyclopropyl-5-fluoro-6-methyl-<i>N</i><sup>4</sup>′-(tetrahydro-2-furanylmethyl)-3,4′-biphenyldicarboxamide (<b>7</b>)</h3><div class="NLM_p last"><i>N</i>-Cyclopropyl-3-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (<b>25a</b>, 30 mg, 0.10 mmol), 4-bromo-<i>N</i>-(tetrahydro-2-furanylmethyl)benzamide (<b>28</b>, 27 mg, 0.10 mmol), tetrakis(triphenylphosphine)palladium (7.0 mg, 6.1 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (1M, 0.45 mL) were mixed in propan-2-ol (2 mL) and heated at 90 °C under nitrogen for 18 h. The reaction was filtered, the residue washed with DCM, and the combined filtrate and washings reduced to dryness. The resulting material was purified by chromatography on a silica cartridge (8 g) eluting with ethyl acetate/cyclohexane (1:2, then 1:1 and 3:1). Appropriate fractions were reduced to dryness under vacuum to give the desired product (17 mg, 45%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.64 (t, <i>J</i> = 5.5 Hz, 1H), 8.53 (d, <i>J</i> = 4.0 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 7.63 (d, <i>J</i> = 10.5 Hz, 1H), 7.60 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 2H), 4.00 (m, 1H), 3.79 (q, <i>J</i> = 7.0 Hz, 1H), 3.64 (q, <i>J</i> = 7.0 Hz, 1H), 3.36 (m partially obscured by water, 2H), 2.85 (m, 1H), 2.17 (s, 3H), 1.95−1.77 (m, 3H), 1.63 (m, 1H), 0.70 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 396, retention time 3.01 min.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-Bromo-<i>N</i>-(tetrahydro-2-furanylmethyl)benzamide (<b>28</b>)</h3><div class="NLM_p last">A solution of 4-bromobenzoyl chloride (500 mg, 2.3 mmol) in DCM (5 mL) was treated with sodium carbonate (290 mg) and (tetrahydro-2-furanylmethyl)amine (230 mg, 2.3 mmol) and the mixture stirred at ambient temperature under nitrogen for 16 h. The reaction was filtered, and the solid was washed with DCM. The combined filtrate and washings were filtered through an aminopropyl ion exchange cartridge and the filtrate evaporated under vacuum to give the desired product as a white solid (280 mg, 42%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.63 (t, 1H), 7.80 (d, <i>J</i> = 8.5 Hz, 2H), 7.67 (d, <i>J</i> = 8.5 Hz, 2H), 3.96 (m, 1H), 3.77 (q, <i>J</i> = 7.5 Hz, 1H), 3.62 (q, <i>J</i> = 7.4 Hz, 1H), 3.30 (m, 2H), 1.94−1.75 (m, 3H), 1.59 (m, 1H). LCMS: MH<sup>+</sup> 284/286, retention time 2.66 min. Purity 85%.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i><sup>3</sup>-Cyclopropyl-5-fluoro-6-methyl-<i>N</i><sup>4</sup>′-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,4′-biphenyldicarboxamide (<b>8</b>)</h3><div class="NLM_p last">A solution of 5′-[(cyclopropylamino)carbonyl]-3′-fluoro-2′-methyl-4-biphenylcarboxylic acid (<b>24</b>, 310 mg, 1.0 mmol) in DMF (4.2 mL) was treated with HATU (400 mg, 1.05 mmol) and diisopropylethylamine (450 μL, 2.0 mmol). After 10 min, 200 μL of this mixture was added to 200 μL of a solution of [(2-methyl-1,3-thiazol-4-yl)methyl]amine (260 mg, 0.2 mmol) in DMF (2 mL). The reaction was left at ambient temperature for 16 h before the solvents were evaporated under vacuum. The residue was dissolved in chloroform, loaded onto an aminopropyl ion exchange cartridge (0.5 g), the cartridge washed with chloroform, and the basic material eluted with ethyl acetate/methanol (9:1). The combined chloroform fractions were reduced to dryness to give the desired compound. <sup>1</sup>H NMR (600 M Hz, DMSO-<i>d</i><sub>6</sub>) δ 9.11 (t, <i>J</i> = 6.0 Hz, 1H), 8.52 (d, <i>J</i> = 4.0 Hz, 1H), 8.02 (d, <i>J</i> = 8.5 Hz, 2H), 7.63 (d, <i>J</i> = 10.0 Hz, 1H), 7.60 (s, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.22 (s, 1H), 4.55 (d, <i>J</i> = 6.0 Hz, 2H), 2.85 (m, 1H), 2.64 (s, 3H), 2.17 (s, 3H), 0.70 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 424, retention time 2.95 min.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5′-[(Cyclopropylamino)carbonyl]-3′-fluoro-2′-methyl-4-biphenylcarboxylic acid (<b>24</b>)</h3><div class="NLM_p last">A mixture of <i>N</i>-cyclopropyl-3-fluoro-5-iodo-4-methylbenzamide (<b>23a</b>, 0.85 g, 2.7 mmol), {4-[(methyloxy)carbonyl]phenyl}boronic acid (0.48 g, 2.7 mmol), tetrakis(triphenylphosphine)palladium (0.31 g, 0.27 mmol), and aq sodium hydrogen carbonate (1M, 13 mL) in propan-2-ol (28 mL) was heated at 90 °C for 22 h under nitrogen. The solvents were evaporated under vacuum and the residue treated with methanol (35 mL) and sodium hydroxide (5 mL) at 50 °C for 2 h. The mixture was reduced to dryness under vacuum and the residue dissolved in ethyl acetate water (1:1, 60 mL). The solution was acidified to pH2 with hydrochloric acid (2M), the layers separated, and the aqueous extracted with ethyl acetate (30 mL). The combined organic phases were washed with water, dried (magnesium sulfate), and reduced to dryness under vacuum. The residue was dissolved in ethyl acetate (30 mL), extracted with sodium hydroxide (2M, 2 × 50 mL), and the aqueous phase acidified to pH 1 and extracted with ethyl acetate (3 × 30 mL). The combined organics were dried (magnesium sulfate) and reduced to dryness under vacuum. The resulting solid was dried under vacuum for 2 h to give the desired product (0.28 g, 34%). <sup>1</sup>H NMR (MeOD) δ 8.11 (d, <i>J</i> = 8.3 Hz, 2H), 7.55 (m, 2H), 7.46 (d, <i>J</i> = 8.0 Hz, 2H), 2.84 (m, 1H), 2.20 (s, 3H), 0.78 (m, 2H), 0.62 (m, 2H). LCMS: MH<sup>+</sup> 314, retention time 3.08 min.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-Cyclopropyl-3-fluoro-5-iodo-4-methylbenzamide (<b>23a</b>)</h3><div class="NLM_p last">3-Fluoro-5-iodo-4-methylbenzoic acid (<b>29</b>, 220 g, 0.77 mol) in thionyl chloride (270 mL, 3.70 mol) was heated at 100 °C for 3 h. The excess thionyl chloride was evaporated under vacuum and the residue azeotroped with DCM (×2). The resulting acid chloride was dissolved in DCM (200 mL) and the solution added slowly to a cold (ice/water bath), stirred suspension of cyclopropylamine (110 mL, 1.6 mol) and sodium carbonate (220 g, 2.0 mol) in DCM (500 mL). The reaction was stirred overnight at ambient temperature, diluted with DCM, and washed with water (×2). The combined aqueous washings were extracted with DCM, the DCM fractions combined, dried (sodium sulfate), and partially concentrated under vacuum. The resulting suspension was allowed to stand for 3 h and the solid isolated by filtration, washed with DCM, and dried to give the desired product (184 g). A further batch of the desired product (11 g) was obtained by evaporation of the solvent from the mother liquor and recrystallization of the residue from DCM (150 mL). A final batch of the desired product (30 g) was prepared by chromatography of the mother liquor on a silica cartridge (800 g) eluting with DCM and then ethyl acetate/DCM (5:95). Total yield (225 g, 92%). <sup>1</sup>H NMR (600 M Hz, CDCl<sub>3</sub>) δ 7.93 (s, 1H), 7.42 (d, <i>J</i> = 9.6 Hz, 1H), 6.42 (bs, 1H), 2.88 (m, 1H), 2.38 (s, 3H), 0.87 (m, 2H), 0.64 (m, 2H). LCMS: MH<sup>+</sup> 320, retention time 3.23 min.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-Fluoro-5-iodo-4-methylbenzoic acid (<b>29</b>)</h3><div class="NLM_p last">3-Fluoro-4-methylbenzoic acid (180 g, 1.2 mol) in trifluoromethanesulfonic acid (1.1 L) was cooled to −20 °C. <i>n</i>-Iodosuccimide (270 g, 1.2 mol) was added in portions over 75 min maintaining a temperature of −18 to −19 °C. The reaction was stirred at −20 °C for 4 h, further NIS (55 g, 0.24 mol) added, and the reaction stirred overnight at −20 °C. NIS (19 g, 84 mmol) was added to the reaction and stirring continued for 24 h. The reaction was warmed up to −5 °C and the suspension poured into ice (3 kg) and 10% sodium thiosulfate solution. The aqueous suspension was filtered, and the solid was washed with water and partially dried. The solid was partitioned between ethyl acetate (5 L) and 10% sodium thiosulfate solution (1.5 L) and the organic phase washed with sodium thiosulfate solution. The combined aqueous phases were extracted with ethyl acetate (2 L); the organic phases were combined, dried (sodium sulfate), and concentrated under vacuum to ca. 600 mL. The slurry was allowed to stand for 4 h, the solid filtered off, washed with ethyl acetate, and dried to give the desired product (215 g, 65%). <sup>1</sup>H NMR (250 M Hz, CDCl<sub>3</sub>) δ 10.76 (bs, 1H), 8.34 (s, 1H), 7.72 (d, 1H), 2.45 (s, 3H). LCMS: [M − H]<sup>−</sup> 279, retention time 3.75 min.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i><sup>3</sup>-Cyclopropyl-5-fluoro-6-methyl-<i>N</i><sup>4</sup>′-[2-(methyloxy)ethyl]-3,4′-biphenyldicarboxamide (<b>9</b>)</h3><div class="NLM_p last">A solution of 5′-[(cyclopropylamino)carbonyl]-3′-fluoro-2′-methyl-4-biphenylcarboxylic acid (<b>24</b>, 0.31 g, 1.0 mmol) in DMF (4.2 mL) was treated with HATU (0.40 g, 1.1 mmol) and diisopropylethylamine (450 μL, 2.0 mmol). After 10 min, 200 μL of this mixture was added to 200 μL of a solution of 2-methoxyethylamine (150 mg, 0.20 mmol) in DMF (2 mL). The reaction was left at ambient temperature for 16 h before the solvents were evaporated under vacuum. The residue was dissolved in chloroform, loaded onto an aminopropyl ion exchange cartridge (0.5 g), the cartridge washed with chloroform, and the basic material eluted with ethyl acetate/methanol (9:1). The combined chloroform fractions were reduced to dryness to give the desired compound. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.61 (t, <i>J</i> = 6.0 Hz, 1H), 8.52 (d, <i>J</i> = 4.0 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 7.63 (d, <i>J</i> = 11.0 Hz, 1H), 7.59 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 2H), 3.49−3.44 (4H, m), 3.28 (s, 3H), 2.17 (d, <i>J</i> = 2.0 Hz, 3H), 0.70 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 371, retention time 2.81 min, purity 88%.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i><sup>3</sup>-cyclopropyl-5-fluoro-<i>N</i><sup>4</sup>′-(2-hydroxy-2-methylpropyl)-6-methyl-3,4′-biphenyldicarboxamide (<b>10</b>)</h3><div class="NLM_p last">5′-[(Cyclopropylamino)carbonyl]-3′-fluoro-2′-methyl-4-biphenylcarboxylic acid (<b>24</b>, 50 mg, 0.16 mmol), HATU (61 mg, 0.16 mmol), 1-amino-2-methyl-2-propanol (21 mg, 0.24 mmol), and diisopropylethylamine (31 μL, 0.18 mmol) were mixed in DMF (2 mL) and stirred at ambient temperature under nitrogen for 24 h. A further aliquot of 1-amino-2-methyl-2-propanol (10 mg, 0.12 mmol) was added and stirring continued for 24 h. The reaction was reduced to dryness under vacuum and purified by chromatography on a silica cartridge (10 g) eluting with an ethyl acetate/cyclohexane gradient (50−100%) and then methanol/ethyl acetate (1−3%). Appropriate fractions were reduced to dryness, to give the desired compound (35 mg, 57%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.53 (d, <i>J</i> = 4.0 Hz, 1H), 8.34 (t, <i>J</i> = 6.0 Hz, 1H), 7.97 (d, <i>J</i> = 8.5 Hz, 2H), 7.63 (d, <i>J</i> = 10.5 Hz, 1H), 7.60 (s, 1H), 7.49 (d, <i>J</i> = 8.0 Hz, 2H), 4.58 (s, 1H), 3.29 (d, <i>J</i> = 6.0 Hz, 2H), 2.85 (m, 1H), 2.17 (d, <i>J</i> = 2.5 Hz, 3H), 1.12 (s, 3H), 0.70 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 385, retention time 2.73 min.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-(5-Cyclopropylcarbamoyl-2-methyl-phenyl)-<i>N</i>-cyclopropylmethyl-nicotinamide (<b>11</b>)</h3><div class="NLM_p last">6-Chloro-<i>N</i>-cyclopropylmethylnicotinamide (<b>27a</b>, 26 mg, 0.10 mmol), <i>N</i>-cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (<b>25b</b>, 30 mg, 0.10 mmol), aq sodium carbonate (2N, 0.5 mL), and tetrakis(triphenylphosphine)palladium (4.0 mg, 3.5 x10<sup>−3</sup> mmol) were heated at 90 °C in DMF (1 mL) for 3 h. The reaction was adsorbed onto silica and purified by chromatography on a silica cartridge (5 g), eluting with an ethyl acetate/cyclohexane gradient (0 to 100%), and then acetone. The solvent was evaporated from the product fractions under vacuum and the residue triturated with diethyl ether to give the desired product as a cream solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.11 (s, 1H), 8.84 (t, <i>J</i> = 5.5 Hz, 1H), 8.48 (d, <i>J</i> = 4.0 Hz, 1H), 8.31 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.0 Hz, 1H), 7.88 (s, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.70 (d, <i>J</i> = 8.5 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 3.20 (t, <i>J</i> = 6.5 Hz, 2H), 2.86 (m, 1H), 2.37 (s, 3H), 1.06 (m, 1H), 0.69 (m, 2H), 0.57 (m, 2H), 0.46 (m, 2H), 0.26 (m, 2H). LCMS: MH<sup>+</sup> 350, retention time 2.70 min</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-Cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (<b>25b</b>)</h3><div class="NLM_p last"><i>N</i>-Cyclopropyl-3-iodo-4-methylbenzamide (<b>23b</b>, 1.1 g, 3.6 mmol), bis(pinnacolato)diboron (1.9 g, 7.3 mmol), potassium acetate (1.8 g, 18 mmol), and Pd(dppf)Cl<sub>2</sub> (55 mg, 75 × 10<sup>−3</sup> mmol) were heated at 85 °C in DMF (30 mL) for 4.5 h. The cooled reaction was adsorbed onto silica and purified by chromatography on a silica cartridge (10 g), eluting with an ethyl acetate/cyclohexane gradient (0 to 100%). The solvent was evaporated from the product fractions under vacuum and the residue triturated with cyclohexane to give the desired product as a beige solid (650 mg, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 4.0 Hz, 1H), 8.06 (d, <i>J</i> = 2.0 Hz, 1H), 7.76 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 2.82 (m, 1H), 2.48 (s, 3H), 1.30 (s, 12H), 0.66 (m, 2H), 0.56 (m, 2H).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-Cyclopropyl-3-iodo-4-methylbenzamide (<b>23b</b>)</h3><div class="NLM_p last">3-Iodo-4-methylbenzoic acid (1.0 g, 3.8 mmol) was heated at 80 °C in thionyl chloride (10 mL, 140 mmol) for 2 h. The reaction was allowed to cool to room temperature and the excess thionyl chloride evaporated under vacuum. The residue was dissolved in DCM (10 mL), and cyclopropylamine (0.32 mL, 4.6 mmol) and sodium carbonate (2.0 g) were added to the solution. The reaction was stirred at room temperature for 18 h, filtered, and the filtrate reduced to dryness under vacuum. The residue was triturated with diethyl ether to give <i>N</i>-cyclopropyl-3-iodo-4-methylbenzamide as a white solid (1.1 g, 96%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.46 (d, <i>J</i> = 4.0 Hz, 1H), 8.24 (d, <i>J</i> = 1.5 Hz, 1H), 7.74 (dd, <i>J</i> = 7.8 Hz, <i>J</i> = 1.8 Hz, 1H), 7.38 (d, <i>J</i> = 8.0 Hz, 1H), 2.82 (m, 1H), 2.38 (s, 3H), 0.67 (m, 2H), 0.55 (m, 2H).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 6-Chloro-<i>N</i>-cyclopropylmethylnicotinamide (<b>27a</b>)</h3><div class="NLM_p last">6-Bromonicotinic acid (1.5 g, 7.6 mmol) was heated at 100 °C in thionyl chloride (5.0 mL, 69 mmol) for 2 h. The excess thionyl chloride was evaporated under vacuum and residue was dissolved in DCM (15 mL), and sodium carbonate (1.5 g) was added to the mixture followed by slow addition of cyclopropylmethylamine (2.0 mL). The reaction was stirred at room temperature overnight, filtered, and the residue washed with DCM (30 mL) and then ethyl acetate (30 mL). The combined filtrate and washings were reduced to dryness under vacuum. The residue was purified by dissolving in DCM, applying to a silica cartridge and eluting with ethyl acetate. The solvent was evaporated from the eluent fractions under vacuum and the residue further dried under vacuum to give 6-chloro-<i>N</i>-cyclopropylmethylnicotinamide as a white solid (1.2 g, 62%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.83 (m, 2H), 8.25 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 2.5 Hz, 1H), 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 3.15 (t, <i>J</i> = 5.8 Hz, 2H), 1.02 (m, 1H), 0.44 (m, 2H), 0.24 (m, 2H).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-{5-[(Cyclopropylamino)carbonyl]-2-methylphenyl}-<i>N</i>-(cyclopropylmethyl)-2-pyridinecarboxamide (<b>12</b>)</h3><div class="NLM_p last">5-Bromo-<i>N</i>-(cyclopropylmethyl)-2-pyridinecarboxamide (<b>27b</b>, 44 mg, 0.27 mmol) and <i>N</i>-cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (<b>25b</b>, 50 mg, 0.17 mmol), aq sodium carbonate (2N, 1 mL), and tetrakis(triphenylphosphine)palladium (6 mg, 5.2 × 10<sup>−3</sup> mmol) were heated at 80 °C in DMF (3 mL) for overnight. The reaction was diluted with ethyl acetate, dried (magnesium sulfate), and the solution filtered through a silica cartridge (5 g). The cartridge was washed with further ethyl acetate and the combined filtrate and washings reduced to dryness under vacuum. The residue was triturated with diethyl ether to give the desired product. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.03 (d, <i>J</i> = 2.0 Hz, 1H), 8.82 (t, <i>J</i> = 5.5 Hz, 1H), 8.73 (d, <i>J</i> = 2.0 Hz, 1H), 8.44 (d, 4.5 Hz, 1H), 8.21 (d, <i>J</i> = 2.5 Hz, d), 7.80 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 1.5 Hz, 1H), 7.75 (d, <i>J</i> = 2.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 1H), 3.17 (t, <i>J</i> = 6.5 Hz, 2H), 2.84 (m, 1H), 2.27 (s, 3H), 1.05 (m, 1H), 0.67 (m, 2H), 0.55 (m, 2H), 0.44 (m, 2H), 0.23 (m, 2H). LCMS: MH<sup>+</sup> 350, retention time 2.62 min</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-Bromo-<i>N</i>-(cyclopropylmethyl)-2-pyridinecarboxamide (<b>27b</b>)</h3><div class="NLM_p last">5-Bromo-2-pyridinecarboxylic acid (51 mg, 0.25 mmol) was heated in thionyl chloride (1.0 mL, 14 mmol) at 85 °C for 2 h. The excess thionyl chloride was evaporated under vacuum, and the residue was dissolved in DCM (2 mL) and treated with cyclopropylmethylamine (0.10 mL) and potassium carbonate (200 mg). The reaction was stirred at room temperature for ∼2 h and then left to stand for 72 h. The reaction was filtered and the residue washed with DCM (∼2 mL). The combined filtrate and washings (pale-yellow solution) were reduced to dryness under a stream of nitrogen. The residual gum was triturated with diethyl ether, filtered, and the filtrate diluted with cyclohexane. The solvents were evaporated under vacuum to give the desired product as cream-colored waxy solid (44 mg, 68%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.81 (bt, 1H), 8.77 (d, <i>J</i> = 2.3 Hz, 1H), 8.24 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 2.3 Hz, 1H), 7.97 (d, <i>J</i> = 8.3 Hz, 1H), 3.16 (t, <i>J</i> = 6.5 Hz, 2H), 1.05 (m, 1H), 0.42 (m, 2H), 0.24 (m, 2H). LCMS: MH<sup>+</sup> 255/257, retention time 2.83 min.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-(cyclopropylmethyl)-3-pyridinecarboxamide (<b>13</b>)</h3><div class="NLM_p last">6-Chloro-<i>N</i>-(cyclopropylmethyl)-3-pyridinecarboxamide (<b>27a</b>, 26 mg, 0.10 mmol), <i>N</i>-cyclopropyl-5-fluoro-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (<b>25a</b>, 32 mg, 0.10 mmol), tetrakis(triphenylphosphino)palladium (2.0 mg, 1.7 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (1M, 0.5 mL) were mixed in propan-2-ol (2 mL) and heated at reflux for 18 h. The cooled reaction was diluted with ethyl acetate and applied to a silica cartridge (5 g), the cartridge was washed with ethyl acetate and the combined filtrate and washings reduced to dryness under vacuum. The residual glass was dissolved in ethyl acetate/methanol and applied to an SCX-2 ion exchange cartridge. The product was eluted with 0.88 ammonia/ethyl acetate/methanol, the solvents evaporated under vacuum, and the residue triturated with diethyl ether/cyclohexane to give the desired product as a white solid (18 mg, 49%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.14 (d, <i>J</i> = 1.5 Hz, 1H), 8.87 (t, <i>J</i> = 5.5 Hz, 1H), 8.58 (d, <i>J</i> = 3.5 Hz, 1H), 8.35 (dd, <i>J</i> = 8.5 Hz, <i>J</i> = 2.0 Hz, 1H), 7.78 (s, 1H), 7.75−7.69 (m, 2H), 3.21 (t, <i>J</i> = 6.0 Hz, 2H), 2.87 (m, 1H), 2.27 (s, 3H), 1.08 (m, 1H), 0.71 (m, 2H), 0.60 (m, 2H), 0.48 (m, 2H), 0.28 (m, 2H). LCMS: MH<sup>+</sup> 368, retention time 2.81 min. Anal. Calcd. for C<sub>21</sub>H<sub>22</sub>FN<sub>2</sub>O<sub>2</sub>: C, 68.65; H, 6.04; N, 11.44. Found: C, 68.32; H, 6.01; N, 11.17.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-Cyclopropyl-5-fluoro-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (<b>25a</b>)</h3><div class="NLM_p last"><i>N</i>-Cyclopropyl-3-fluoro-5-iodo-4-methylbenzamide (<b>23a</b>, 6.0 g, 19 mmol), bispinnacolatodiboron (7.2 g, 28 mmol), potassium acetate (9.2 g, 94 mmol), and Pd(dppf)Cl<sub>2</sub> (150 mg, 0.20 mmol) were mixed in anhydrous DMF (130 mL) and heated at 90 °C for 19 h. The cooled reaction was adsorbed onto silica and purified by chromatography on silica cartridges (40 g × 2) eluting with ethyl acetate/cyclohexane (10 then 15%). The product fractions were combined the solvents evaporated under vacuum. The residue was recrystallized from cyclohexane to give the desired product as a white solid (3.0 g, 54%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.73 (s, 1H), 7.60 (d, <i>J</i> = 11.8 Hz, 1H), 6.32 (bs, 1H), 2.89 (m, 1H), 2.49 (d, <i>J</i> = 2.3 Hz, 3H), 1.36 (s, 12H), 0.88 (m, 2H), 0.65 (m, 2H).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-(2,2-dimethylpropyl)-3-pyridinecarboxamide (<b>2</b>)</h3><div class="NLM_p last">6-Chloro-<i>N</i>-(2,2-dimethylpropyl)-3-pyridinecarboxamide (<b>30</b>, 560 mg, 2.3 mmol), <i>N</i>-cyclopropyl-5-fluoro-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (<b>25a</b>, 790 mg, 2.5 mmol), tetrakis(triphenylphosphine)palladium (30 mg, 0.025 mmol), and aq sodium hydrogen carbonate (1M, 3 mL) were mixed in propan-2-ol (10 mL) and heated at 90 °C for 18 h. The propan-2-ol was evaporated, the residue dissolved with ethyl acetate, applied to an SCX-2 ion exchange cartridge (10 g), and the cartridge washed with ethyl acetate and then methanol. The product was eluted from the cartridge with 0.880 ammonia/ethyl acetate/methanol and the solvents evaporated in vacuo. The residue was triturated with diethyl ether to give the desired product as a white solid (500 mg, 57%). The combined ethyl acetate and methanol washings were reduced to dryness in vacuo, the residue was dissolved in a mixture of acetone and methanol and applied to an SCX-2 ion exchange cartridge (10 g), and the cartridge was washed with methanol and eluted with 0.880 ammonia/methanol. The basic fraction was reduced to dryness in vacuo to give a second batch of the desired product as a white solid (200 mg, 22%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.11 (d, <i>J</i> = 1.5 Hz, 1H), 8.63 (t, <i>J</i> = 6.0 Hz, 1H), 8.56 (d, <i>J</i> = 4.0 Hz, 1H), 8.33 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.0 Hz, 1H), 7.76 (s, 1H), 7.73−7.68 (m, 2H), 3.16 (d, <i>J</i> = 6.5 Hz, 2H), 2.86 (m, 1H), 2.26 (d, <i>J</i> = 2.0 Hz, 3H), 0.93 (s, 9H), 0.70 (m, 2H), 0.58 (m, 2H). LCMS: MH<sup>+</sup> 384, retention time 3.01 min. Anal. Calcd. for C<sub>22</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>2</sub>: C, 68.9; H, 6.80; F, 4.95; N, 11.0. Found: C, 68.8; H, 6.72; F, 5.03; N, 10.82.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 6-Chloro-<i>N</i>-(2,2-dimethylpropyl)-3-pyridinecarboxamide (<b>30</b>)</h3><div class="NLM_p last">6-Chloro-3-pyridinecarboxylic acid (500 mg, 3.1 mmol) in thionyl chloride (3.5 mL, 48 mmol) was heated at 100 °C for 1.5 h. The excess thionyl chloride was evaporated under vacuum and the solid residue dissolved in DCM (20 mL). This mixture was treated with 2,2-dimethylpropylamine (1.0 mL, 16 mmol) and sodium carbonate (1.7 g, 16 mmol) and stirred for 15 h at ambient temperature. The reaction was filtered and the solvent evaporated to give the title compound (840 mg, quant). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 2.3 Hz, 1H), 8.61 (bt, 1H), 8.25 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 2.5 Hz, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 1H), 3.12 (d, <i>J</i> = 6.3 Hz, 2H), 0.90 (s, 9H).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-(2-methylpropyl)-3-pyridinecarboxamide (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared as for <b>2</b> using 6-chloro-<i>N</i>-(2-methylpropyl)-3-pyridinecarboxamide (<b>31</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.11 (d, <i>J</i> = 1.5 Hz, 1H), 8.74 (t, <i>J</i> = 6.0 Hz, 1H), 8.56 (d, <i>J</i> = 4.0 Hz, 1H), 8.32 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.5 Hz, 1H), 7.76 (s, 1H), 7.73−7.68 (m, 2H), 3.13 (t, <i>J</i> = 6.5 Hz, 2H), 2.85 (m, 1H), 2.26 (d, <i>J</i> = 2.0 Hz, 3H), 1.87 (m, 1H), 0.92 (d, <i>J</i> = 7.0 Hz), 0.70 (m, 2H), 0.58 (m, 2H). LCMS: MH<sup>+</sup> 370, retention time 2.86 min. Anal. Calcd. for C<sub>21</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>: C, 68.27; H, 6.55; N, 11.37. Found: C, 68.10; H, 6.52; N, 11.31.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 6-Chloro-<i>N</i>-(2-methylpropyl)-3-pyridinecarboxamide (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared in a similar manner to <b>30</b>, using 2-methylpropylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 2.0 Hz, 1H), 8.73 (bt, 1H), 8.23 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 2.4 Hz, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 1H), 3.09 (t, <i>J</i> = 6.0 Hz, 2H), 1.84 (m, 1H), 0.89 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-[(1<i>R</i>)-1,2-dimethylpropyl]-3-pyridinecarboxamide (<b>15</b>)</h3><div class="NLM_p last">6-Chloro-[(<i>R</i>)-(−)-3-methyl-2-butyl]nicotinamide (<b>32</b>, 100 mg, 0.44 mmol), {5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}boronic acid (<b>26a</b>, 100 mg, 0.42 mmol), tetrakis(triphenylphosphine)palladium (10 mg, 8.7 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (4 mL) were mixed in propan-2-ol (8 mL) and heated at 90 °C under nitrogen for 18 h. The solvents were evaporated from the cooled reaction under vacuum and the residue dissolved as far as possible in ethyl acetate. The solution was applied to an SCX-2 ion exchange cartridge (10 g) and the cartridge washed with ethyl acetate. The product was eluted with 0.880 ammonia/methanol and the solvents evaporated under vacuum. The residue was redissolved in ethyl acetate and filtered through a silica cartridge (0.5 g). The filtrate was reduced to dryness under vacuum and the residue triturated with diethyl ether to give the desired compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.10 (d, <i>J</i> = 1.0 Hz, 1H), 8.57 (d, <i>J</i> = 4.0 Hz, 1H), 8.43 (d, <i>J</i> = 8.0 Hz, 1H), 8.32 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.0 Hz, 1H), 7.76 (s, 1H), 7.72−7.68 (m, 2H), 3.88 (m, 1H), 2.86 (m, 1H), 2.26 (d, <i>J</i> = 1.5 Hz, 3H), 1.79 (m, 1H), 1.14 (d, <i>J</i> = 7.0 Hz, 3H), 0.92 (d, <i>J</i> = 7.0 Hz, 6H), 0.70 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 384, retention time 2.93 min.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 6-Chloro-[(<i>R</i>)-(−)-3-methyl-2-butyl]nicotinamide (<b>32</b>)</h3><div class="NLM_p last">6-Chloro-3-pyridinecarboxylic acid (3.0 g, 19 mmol) in thionyl chloride (8.0 mL, 110 mmol) was heated at 90 °C for 2 h. The excess thionyl chloride was removed under vacuum and the residue dissolved in DCM (30 mL). A portion (5 mL) of this mixture was treated with (<i>R</i>)-(−)-3-methyl-2-butylamine (0.50 mL), sodium carbonate (1.0 g), and DCM (5 mL). The reaction was stirred at ambient temperature overnight, filtered, and the filtrate reduced to dryness under vacuum. The residue was further dried under vacuum to give the desired product as a solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.82 (d, <i>J</i> = 2.5 Hz, 1H), 8.43 (d, <i>J</i> = 8.3 Hz, 1H), 8.24 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 2.5 Hz, 1H), 7.63 (d, <i>J</i> = 8.3 Hz, 1H), 3.83 (m, 1H), 1.76 (m, 1H), 1.10 (d, <i>J</i> = 6.8 Hz, 3H), 0.89 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 2.3 Hz, 6H). LCMS: MH<sup>+</sup> 227/229, retention time 2.60 min.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> {5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}boronic Acid (<b>26a</b>)</h3><div class="NLM_p last">A stirred solution of <i>N</i>-cyclopropyl-3-fluoro-5-iodo-4-methylbenzamide (<b>23a</b>, 0.50 g, 1.6 mmol) in THF (20 mL) was treated with sodium hydride (60% in mineral oil, 120 mg, 3.1 mmol). The mixture was cooled to −75 °C and <i>n</i>-butyl lithium (1.6 M in hexanes, 9.8 mL, 16 mmol) added slowly maintaining the temperature below −62 °C. Triisopropylborate (4.3 mL, 19 mmol) was added dropwise over 10 min, maintaining the temperature below −65 °C, and the mixture was stirred at −75 °C for 4 h and then allowed to warm to ambient temperature overnight. The reaction was recooled to −75 °C and quenched with water (20 mL). The mixture was allowed to warm to ambient temperature and stirred for 30 min. The mixture was concentrated and the residue partitioned between ethyl acetate and saturated ammonium chloride. The aqueous phase was extracted with ethyl acetate (×2), the combined organic phases dried (sodium sulfate), and the solvent evaporated under vacuum. The residue was dissolved in ethyl acetate and the solvent re-evaporated, and the residue was dissolved in DCM and applied to a silica column. The column was eluted with an ethyl acetate/cyclohexane gradient (50−100%) and then with methanol. Appropriate fractions were reduced to dryness under vacuum to give the desired compound (270 mg, 73%). <sup>1</sup>H NMR (MeOD) δ 7.58 (s, 1H), 7.39 (d, <i>J</i> = 10.6 Hz, 1H), 2.82 (m, 2H), 2.31 (s, 3H), 0.79 (m, 2H), 0.63 (m, 2H). LCMS: MH<sup>+</sup> 238, retention time 2.20 min.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-[(1<i>S</i>)-1,2-dimethylpropyl]-3-pyridinecarboxamide (<b>16</b>)</h3><div class="NLM_p last">6-Chloro-[(<i>S</i>)-(+)-3-methyl-2-butyl]nicotinamide (<b>33</b>, 100 mg, 0.44 mmol), {5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}boronic acid (<b>26a</b>, 100 mg, 0.42 mmol), tetrakis(triphenylphosphine)palladium (10 mg, 8.7 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (4.0 mL) were mixed in propan-2-ol (8 mL) and heated at 90 °C under nitrogen for 18 h. The solvents were evaporated from the cooled reaction under vacuum and the residue dissolved as far as possible in ethyl acetate. The solution was applied to an SCX-2 ion exchange cartridge (10 g) and the cartridge washed with ethyl acetate. The product was eluted with 0.880 ammonia/methanol and the solvents evaporated under vacuum. The residue was redissolved in ethyl acetate and filtered through a silica cartridge (0.5 g). The filtrate was reduced to dryness under vacuum and the residue triturated with diethyl ether to give the desired compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.10 (s, 1H), 8.57 (d, <i>J</i> = 3.5 Hz, 1H), 8.43 (d, <i>J</i> = 8.5 Hz, 1H), 8.32 (dd, <i>J</i> = 8.0 Hz, <i>J</i> = 2.5 Hz, 1H), 7.76 (s, 1H), 7.72−7.68 (m, 2H), 3.88 (m, 1H), 2.86 (m, 1H), 2.26 (d, <i>J</i> = 1.5 Hz, 3H), 1.79 (m, 1H), 1.14 (d, <i>J</i> = 6.5 Hz, 3H), 0.92 (d, <i>J</i> = 7.0 Hz, 6H), 0.70 (m, 2H), 0.58 (m, 2H). LCMS: MH<sup>+</sup> 384, retention time 2.93 min.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 6-Chloro-[(<i>S</i>)-(+)-3-methyl-2-butyl]nicotinamide (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared in a similar manner to <b>32</b>, using (<i>S</i>)-(+)-3-methyl-2-butylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.82 (d, <i>J</i> = 2.3 Hz, 1H), 8.42 (d, <i>J</i> = 8.5 Hz, 1H), 8.24 (dd, <i>J</i> = 8.3 Hz, <i>J</i> = 2.3 Hz, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 1H), 3.83 (m, 1H), 1.75 (m, 1H), 1.10 (d, <i>J</i> = 6.8 Hz, 3H), 0.89 (dd, <i>J</i> = 6.9 Hz, <i>J</i> = 2.4 Hz, 6H). LCMS: MH<sup>+</sup> 227/229, retention time 2.60 min.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-[(1<i>R</i>)-1,2,2-trimethylpropyl]-3-pyridinecarboxamide (<b>17</b>)</h3><div class="NLM_p last">6-Chloro-<i>N</i>-[(1<i>R</i>)-1,2,2-trimethylpropyl]-3-pyridinecarboxamide (<b>34</b>, 100 mg, 0.42 mmol), {5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}boronic acid (<b>26a</b>, 100 mg, 0.42 mmol), tetrakis(triphenylphosphine)palladium (10 mg, 8.7 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (4.0 mL) were mixed in propan-2-ol (8 mL) and heated at 90 °C under nitrogen for 18 h. The solvents were evaporated from the cooled reaction under vacuum and the residue dissolved as far as possible in ethyl acetate. The solution was applied to an SCX-2 ion exchange cartridge (10 g) and the cartridge washed with ethyl acetate. The product was eluted with 0.880 ammonia/methanol and the solvents evaporated under vacuum. The residue was redissolved in ethyl acetate and filtered through a silica cartridge (0.5 g). The filtrate was reduced to dryness under vacuum and the residue triturated with diethyl ether to give the desired compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.09 (d, <i>J</i> = 2.0 Hz, 1H), 8.57 (d, <i>J</i> = 4.0 Hz, 1H), 8.32−8.26 (m, 2H), 7.76 (s, 1H), 7.72−7.68 (m, 2H), 4.02 (m, 1H), 2.86 (m, 1H), 2.27 (s, 3H), 1.12 (d, <i>J</i> = 7.0 Hz, 3H), 0.93 (s, 9H), 0.70 (m, 2H), 0.57 (m, 2H). LCMS: MH<sup>+</sup> 398, retention time 3.05 min.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 6-Chloro-<i>N</i>-[(1<i>R</i>)-1,2,2-trimethylpropyl]-3-pyridinecarboxamide (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared in a similar manner to <b>32</b>, using (<i>R</i>)-3,3-dimethyl-2-butylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.80 (d, <i>J</i> = 2.5 Hz, 1H), 8.26−8.21 (m, 2H), 7.63 (d, <i>J</i> = 8.5 Hz, 1H), 3.96 (m, 1H), 1.08 (d, <i>J</i> = 6.8 Hz, 3H), 0.90 (s, 9H). LCMS: MH<sup>+</sup> 241/243, retention time 2.77 min.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 6-{5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}-<i>N</i>-[(1<i>S</i>)-1,2,2-trimethylpropyl]-3-pyridinecarboxamide (<b>18</b>)</h3><div class="NLM_p last">6-Chloro-<i>N</i>-[(1<i>S</i>)-1,2,2-trimethylpropyl]-3-pyridinecarboxamide (<b>35</b>, 100 mg, 0.42 mmol), {5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl}boronic acid (<b>26a</b>, 100 mg, 0.42 mmol), tetrakis(triphenylphosphine)palladium (10 mg, 8.7 × 10<sup>−3</sup> mmol), and aq sodium hydrogen carbonate (1M, 4.0 mL) were mixed in propan-2-ol (8 mL) and heated at 90 °C under nitrogen for 18 h. The solvents were evaporated from the cooled reaction under vacuum and the residue dissolved as far as possible in ethyl acetate. The solution was applied to an SCX-2 ion exchange cartridge (10 g) and the cartridge washed with ethyl acetate. The product was eluted with 0.880 ammonia/methanol and the solvents evaporated under vacuum. The residue was redissolved in ethyl acetate and filtered through a silica cartridge (0.5 g). The filtrate was reduced to dryness under vacuum and the residue triturated with diethyl ether to give the desired compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.09 (d, <i>J</i> = 2.0 Hz, 1H), 8.57 (d, <i>J</i> = 4.0 Hz, 1H), 8.32−8.26 (m, 2H), 7.76 (s, 1H), 7.72−7.68 (m, 2H), 4.02 (m, 1H), 2.86 (m, 1H), 2.27 (d, <i>J</i> = 1.5 Hz, 3H), 1.12 (d, <i>J</i> = 6.5 Hz, 3H), 0.93 (s, 9H), 0.70 (m, 2H), 0.58 (m, 2H). LCMS: MH<sup>+</sup> 398, retention time 3.05 min.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 6-Chloro-<i>N</i>-[(1<i>S</i>)-1,2,2-trimethylpropyl]-3-pyridinecarboxamide (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared in a similar manner to <b>32</b>, using (<i>S</i>)-3,3-dimethyl-2-butylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.80 (d, <i>J</i> = 2.5 Hz, 1H), 8.26−8.21 (m, 2H), 7.63 (d, <i>J</i> = 8.3 Hz, 1H), 3.96 (m, 1H), 1.08 (d, <i>J</i> = 7.0 Hz, 3H), 0.90 (s, 9H). LCMS: MH<sup>+</sup> 241/243, retention time 2.79 min.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Protein Crystallography Method</h3><div class="NLM_p last">The crystal structure of human unphosphorylated p38α with compound <b>11</b> was determined by closely following methodology previously described.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> More specificially in this case an apo-crystal was soaked (and simultaneously cryoprotected) with compound <b>11</b> at 0.25 mM for ∼2 days in soaking buffer containing 10% glycerol prior to data collection at 100 K (using an Oxford Cryostream). The X-ray diffraction data were collected on an in-house Rigaku-MSC RuH2R rotating anode X-ray generator with a RAXIS IV++ image-plate detector. The data were processed with HKL data processing package<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and CCP4 program suite<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and the structure solved using the native p38 coordinates (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1WFC">1WFC</a>) as the initial model in refinement by REFMAC.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The final <i>R</i> factor and R-free achieved for the complex were 18.1% and 24.9%, respectively and the coordinates have been deposited in the PDB as entry 3iph.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> p38α Kinase Assay, Fluorescence Polarization Method</h3><div class="NLM_p last">Fluorescence polarization assays used GST-tagged p38α (activated using MKK6 and repurified) and an ATP-competitive rhodamine-green labeled fluoroligand (2-(6-amino-3-imino-3<i>H</i>-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1<i>H</i>-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid). These components were dissolved in a buffer of final composition 62.5 mM Hepes, pH 7.5, 1.25 mM CHAPS, 1 mM DTT, 12.5 mM MgCl<sub>2</sub>, with final concentrations of 12 nM of p38α and 5 nM fluoroligand. Then 30 μL of this mixture were added to wells containing 1 μL of test compound (0.28 nM−16.6 μM) and incubated for 30−60 min at room temperature. Fluorescence anisotropy was read in a Molecular Devices Acquest (excitation 485 nm/emission 535 nm). The Cheng−Prusoff equation (<contrib-group person-group-type="allauthors">Cheng, Y.-C.; Prusoff, W. H.</contrib-group> <cite>Biochem. Pharmacol.</cite> <span class="NLM_year">1973</span>, <em>22</em>, 3099−3108), <i>K</i><sub>i</sub> = IC<sub>50</sub>(1 + ([S]/<i>K</i><sub>m</sub>)), was used to calculate <i>K</i><sub>i</sub> from determined IC<sub>50</sub> for activity assays. To calculate <i>K</i><sub>i</sub> from determined IC<sub>50</sub> for fluorescence polarization assays a modification of the Cheng−Prusoff equation was used (<span class="references__authors">Cheng, H. C.</span> <cite>Pharmacol. Res.</cite> <span class="NLM_year">2005</span>, <em>50</em>, 21−40). <i>K</i><sub>i</sub> = IC<sub>50</sub>(1 + ((<i>n</i>[E])/<i>K</i><sub>d</sub>)) where <i>n</i> is the fraction of enzyme competent to bind fluoroligand. <i>K</i><sub>i</sub> values for 381 compounds in the fluorescence polarization assay correlate with those from an activity assay with <i>r</i><sup>2</sup> = 0.9.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Cytokine Production in Human PBMC</h3><div class="NLM_p last">PBMC were prepared from heparinized human blood from normal volunteers by centrifugation on hystopaque at 1000<i>g</i> for 30 min. The cells were collected from the interface, washed by centrifugation (1300<i>g</i>, 10 min) and resuspended in assay buffer (RPMI1640 containing 10% fetal calf serum, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, and 1% penicillin/streptomycin) at 5 × 10<sup>5</sup> cells/mL. Then 100 μL cells were added to microtiter wells containing 0.5 or 1.0 μL of an appropriately diluted compound solution. After the assay plates had been incubated for 1 h at 37 °C, 5% CO<sub>2</sub>, 25 μL of LPS (1 ng/mL final) was added and the samples incubated at 37 °C, 5% CO<sub>2</sub> for a further 20 h. The supernatant was removed and the concentrations of TNFα determined by enzyme linked immunosorbant assay (ELISA) or using a multiplex bead technology (Luminex) or antibody complex and electrochemiluminescence (Igen).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Cytokine Production in Human Whole Blood</h3><div class="NLM_p last">Heparinized blood drawn from normal volunteers was dispensed (100 μL) into microtiter plate wells containing 0.5 or 1.0 μL of an appropriately diluted compound solution. After 1 h incubation at 37 °C, 5% CO<sub>2</sub>, 25 μL of LPS solution in RPMI 1640 (containing 1% <span class="smallcaps smallerCapital">l</span>-glutamine and 1% penicillin/streptomycin) was added (50 ng/mL final). The samples were incubated at 37 °C, 5% CO<sub>2</sub> for 20 h, 100−150 μL physiological saline (0.138% NaCl) was added, and diluted plasma was collected using a Platemate or Biomek FX liquid handling robot after centrifugation at 1300<i>g</i> for 10 min. Plasma TNFα content was determined by enzyme linked immunosorbant assay (ELISA) or using a multiplex bead technology (Luminex).</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> TNFα ELISA</h3><div class="NLM_p last">Human TNFα was assayed using a commercial assay kit (AMS Biotechnology 211-90-164-40) according to the manufacturer’s instructions but with TNFα calibration curves prepared using Pharmingen TNFα (cat. no. 555212).</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> LUMINEX Assay</h3><div class="NLM_p last">First, 45 μL of luminex assay buffer (PBS/1%BSA/0.025% Triton X-100) was added to 96-well microtiter Millipore filter plates (MABVN1210) followed by 5 μL of HWB or PBMC supernatant. Then 50 μL of Luminex microspheres coated in a primary antibody against human TNFα (1 × 10<sup>5</sup> beads/mL) were added and the plates were shaken and then incubated at 4 °C overnight in the dark. Standard curves for TNFα were present on each plate (0−2000 pg/mL for TNFα). Plates were then washed under low vacuum filtration and 50 μL/well of diluted biotinylated secondary antibodies added. The plates were shaken for 1 h at room temperature, washed, and then 50 μL/well of streptavidin phycoerythrin added (Zymed 15-4301) at 0.25 μg/mL. The plates were shaken for 30 min in the dark, and after a final wash, the beads were resuspended in 120 μL of Sheath fluid (BioRad cat. no. 171-000055) and the plates read on the BioRad multiplex reader.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Data Analysis</h3><div class="NLM_p last">TNFα concentrations were determined from standard curves, and IC<sub>50</sub>s were generated from percent inhibition values using nonlinear least-squares curve fitting, in general with a four-parameter logistic model using Activity Base.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> CYP450 Assay</h3><div class="NLM_p last">The inhibition of recombinant CYP450 mediated <i>O</i>-dealkylase metabolism of pro-fluorescent probe substrates was assessed in a fluorimetric assay with the following recombinant human cytochrome P450′s coexpressed in <i>Escherichia coli</i> with human NADPH reductase (Bactosomes, CYPEX UK), CYP2C9 with the substrate 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid (FCA), CYP1A2 with the substrate ethoxyresorufin (ER), CYP2D6 with the substrate 4-methylaminomethyl-7-methoxycoumarin (MMMC), CYP2C19 with the substrate 3-butyryl-7-methoxycoumarin (BMC), and CYP3A4 with the substrates 7-benzyloxyquinolone (7BQ) and diethoxyfluorescein (DEF). Compounds were incubated at a starting concentration of 5 mM in <2% MeOH. The concentration range for the IC<sub>50</sub> determination assay was 0.1−100 uM (spread over nine points) and included a 0.2 mM NADPH regeneration system.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/jm9004779">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32652" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32652" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">NMR spectrum for compound <b>2</b>, pharmacokinetic protocols for rat cassette, rat discrete, and cynomolgus monkey studies, rat PG-PS model protocol, murine CIA protocol, poster giving further information about modeling used in generation of virtual arrays. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9004779/suppl_file/jm9004779_si_001.pdf">jm9004779_si_001.pdf (208.05 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm9004779" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann L. Walker</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2b6a45450567057c4a47404e596b6c786005484446"><span class="__cf_email__" data-cfemail="df9eb1b1f193f188beb3b4baad9f988c94f1bcb0b2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola M. Aston</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bamborough</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline B. Buckton</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher D. Edwards</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duncan S. Holmes</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine L. Jones</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vipulkumar K. Patel</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Penny A. Smee</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald O. Somers</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Vitulli</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Rd, Stevenage, Hertfordshire SG1 2NY, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Antony Cooper, Suzanne J. deBoeck, Derek Evans, Kathryn J. Smith, Stephen Swanson, and Aurelien Putey for synthetic and medicinal chemistry contributions, Antony D. R. Angell, Yemisi E. Solanke, and Richard A. Williamson for generation of the PBMC and HWB data, Chris Mooney for generation of p38α protein, Margarete Neu for her contribution to the crystallography studies, Klara Valko for generation of CHI logD data, and Chris Luscombe for the statistical modeling. This work was funded by GlaxoSmithKline.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Taylor, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, R. N.</span><span> </span><span class="NLM_article-title">Immunotherapy for rheumatoid arthritis</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1016%2FS0952-7915%2800%2900269-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=11544014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFagtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=611-616&issue=5&author=P.+C.+Taylorauthor=R.+O.+Williamsauthor=R.+N.+Maini&title=Immunotherapy+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for rheumatoid arthritis</span></div><div class="casAuthors">Taylor, P. C.; Williams, R. O.; Maini, R. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">611-616</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Recently published studies confirm that the long-term use of biol. agents targeting TNF-α in therapy for rheumatoid arthritis (RA) gives rise to sustained improvement in symptoms and signs of disease, and in the quality of life.  Furthermore, it has emerged that anti-TNF therapy protects joints from structural damage, which unexpectedly is also obsd. in the patient population showing no apparent benefit in control of signs and symptoms.  Therapeutic benefit is obsd. in established disease that is unresponsive to conventional DMARDS and in early DMARDS-naive RA patients.  Thus, for patients with RA, anti-TNF therapies set a new std. for symptom control and joint protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrubiHzYbnjLbVg90H21EOLACvtfcHk0liso0LXdv1d3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFagtro%253D&md5=a0f5dc2aad455a2a3db1f6e69334da61</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2800%2900269-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252800%252900269-7%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%2BC.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DImmunotherapy%2520for%2520rheumatoid%2520arthritis%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2001%26volume%3D13%26issue%3D5%26spage%3D611%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laydon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heys, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvatter, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemens, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=739-746&author=J.+C.+Leeauthor=J.+T.+Laydonauthor=P.+C.+McDonnellauthor=T.+F.+Gallagherauthor=S.+Kumarauthor=D.+Greenauthor=D.+McNultyauthor=M.+J.+Blumenthalauthor=J.+R.+Heysauthor=S.+W.+Landvatterauthor=J.+E.+Stricklerauthor=M.+M.+McLaughlinauthor=I.+R.+Siemensauthor=S.+M.+Fisherauthor=G.+P.+Liviauthor=J.+R.+Whiteauthor=J.+L.+Adamsauthor=P.+R.+Young&title=A+protein+kinase+involved+in+the+regulation+of+inflammatory+cytokine+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLaydon%26aufirst%3DJ.%2BT.%26aulast%3DMcDonnell%26aufirst%3DP.%2BC.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DMcNulty%26aufirst%3DD.%26aulast%3DBlumenthal%26aufirst%3DM.%2BJ.%26aulast%3DHeys%26aufirst%3DJ.%2BR.%26aulast%3DLandvatter%26aufirst%3DS.%2BW.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DSiemens%26aufirst%3DI.%2BR.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DLivi%26aufirst%3DG.%2BP.%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DA%2520protein%2520kinase%2520involved%2520in%2520the%2520regulation%2520of%2520inflammatory%2520cytokine%2520biosynthesis%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D739%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span> </span><span class="NLM_article-title">p38 MAPK signalling cascades in inflammatory disease</span> <span class="citation_source-journal">Mol. Med. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1016%2FS1357-4310%2899%2901544-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=10498912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=439-447&author=E.+Herlaarauthor=Z.+Brown&title=p38+MAPK+signalling+cascades+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAPK signalling cascades in inflammatory disease</span></div><div class="casAuthors">Herlaar, E.; Brown, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">439-447</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 44 refs.  Inflammatory mediators released during acute and chronic diseases activate multiple intracellular signaling cascades including the mitogen-activated protein kinase (MAPK) signal transduction pathway, which plays a significant role in the recruitment of leukocytes to sites of inflammation.  Stimulation of leukocytes by pro-inflammatory cytokines is known to result in the activation of the MAPK isoform p38.  However, the functional consequences of p38 MAPK activation during leukocyte recruitment, including adhesion, migration and effector functions such as oxidative burst and degranulation, are only just beginning to be elucidated.  Specific p38 inhibitors aimed at reducing the prodn. of inflammatory mediators are now being developed, and might in the future provide more effective treatment for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIhoJ67g0sRrVg90H21EOLACvtfcHk0liso0LXdv1d3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D&md5=3bf8c8ba39b01b5a3188d75b06107709</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2899%2901544-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252899%252901544-0%26sid%3Dliteratum%253Aachs%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DZ.%26atitle%3Dp38%2520MAPK%2520signalling%2520cascades%2520in%2520inflammatory%2520disease%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1999%26volume%3D5%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">New approaches to the treatment of inflammatory disorders small molecules inhibitors of p38 MAP kinase (Review)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.2174%2F156802606775270323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16454763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVantrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=113-149&author=C.+Peiferauthor=G.+Wagnerauthor=S.+Laufer&title=New+approaches+to+the+treatment+of+inflammatory+disorders+small+molecules+inhibitors+of+p38+MAP+kinase+%28Review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase</span></div><div class="casAuthors">Peifer, Christian; Wagner, Gerd; Laufer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-149</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapy of chronic inflammatory diseases like rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) has recently been enriched by the successful launch of the anti-cytokine biologicals Etanercept [tumor necrosis factor (TNF) receptor-p75 Fc fusion protein], Infliximab (chimeric anti-human TNF-α monoclonal antibody), Adalimumab (recombinant human anti-human TNF-α monoclonal antibody), and Anakinra [recombinant form of human interleukin 1β (IL-1) receptor antagonist].  The success of these novel treatments has impressively demonstrated the clin. benefit that can be gained from therapeutic intervention in cytokine signaling, highlighting the central role of proinflammatory cytokine systems like IL-1β and TNF-α to be validated targets.  However, all of the anti-cytokine biologicals available to date are proteins, and therefore suffering to a varying degree from the general disadvantages assocd. with protein drugs.  Therefore, small mol., orally active anti-cytokine agents, which target specific pathways of proinflammatory cytokines, would offer an attractive to anti-cytokine biologicals.  A no. of mol. targets have been identified for the development of such small mol. agents but p38 mitogen-activated protein (MAP) kinase occupies a central role in the regulation of IL-1β and TNF-α signaling network at both the transcriptional and translational level.  Since the mid-1990s, an immense no. of inhibitors of p38 MAP kinase has been characterized in vitro, and to date several compds. have been advanced into clin. trials.  This review will highlight the correlation between effective inhibition of p38 MAP kinase at the mol. target and cellular activity in functional assays of cytokine, particularly TNF-α and IL-1β prodn.  SAR will be discussed regarding activity at the enzyme target, but also with regard to properties required for efficient in vitro and in vivo activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxT_2yIMHnHbVg90H21EOLACvtfcHk0liEyn3Apt6HJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVantrs%253D&md5=584981b91cea4f35a7ffdef80b8b31b2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F156802606775270323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606775270323%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DNew%2520approaches%2520to%2520the%2520treatment%2520of%2520inflammatory%2520disorders%2520small%2520molecules%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%2520%2528Review%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D113%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development (Review)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+Inhibition+of+p38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development+%28Review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0liEyn3Apt6HJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520Inhibition%2520of%2520p38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%2520%2528Review%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braganza, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuperman, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLiberte, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeny, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebino, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volberg, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4339-4344&issue=16&author=K.+F.+McClureauthor=M.+A.+Letavicauthor=A.+S.+Kalgutkarauthor=C.+A.+Gabelauthor=L.+Audolyauthor=J.+T.+Barberiaauthor=J.+F.+Braganzaauthor=D.+Carterauthor=T.+J.+Cartyauthor=S.+R.+Cortinaauthor=M.+A.+Dombroskiauthor=K.+M.+Donahueauthor=N.+C.+Elliottauthor=C.+P.+Gibbonsauthor=C.+K.+Jordanauthor=A.+V.+Kupermanauthor=J.+M.+Labasiauthor=R.+E.+LaLiberteauthor=J.+M.+McCoyauthor=B.+M.+Naimanauthor=K.+L.+Nelsonauthor=H.+T.+Nguyenauthor=K.+M.+Peeseauthor=F.+J.+Sweenyauthor=T.+J.+Taylorauthor=C.+E.+Trebinoauthor=Y.+A.+Abramovauthor=E.+R.+Lairdauthor=W.+A.+Volbergauthor=J.+Zhouauthor=J.+Bachauthor=F.+Lombardo&title=Structure%E2%88%92activity+relationships+of+triazolopyridine+oxazole+p38+inhibitors%3A+identification+of+candidates+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DBarberia%26aufirst%3DJ.%2BT.%26aulast%3DBraganza%26aufirst%3DJ.%2BF.%26aulast%3DCarter%26aufirst%3DD.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DElliott%26aufirst%3DN.%2BC.%26aulast%3DGibbons%26aufirst%3DC.%2BP.%26aulast%3DJordan%26aufirst%3DC.%2BK.%26aulast%3DKuperman%26aufirst%3DA.%2BV.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DLaLiberte%26aufirst%3DR.%2BE.%26aulast%3DMcCoy%26aufirst%3DJ.%2BM.%26aulast%3DNaiman%26aufirst%3DB.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DSweeny%26aufirst%3DF.%2BJ.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrebino%26aufirst%3DC.%2BE.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DVolberg%26aufirst%3DW.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520triazolopyridine%2520oxazole%2520p38%2520inhibitors%253A%2520identification%2520of%2520candidates%2520for%2520clinical%2520development%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D16%26spage%3D4339%26epage%3D4344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Natarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-<i>d</i>]pyrimidones and 3,4-dihydropyrido[4,3-<i>d</i>]pyrimidin-2-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4400</span><span class="NLM_x">–</span> <span class="NLM_lpage">4404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4400-4404&issue=16&author=S.+R.+Natarajanauthor=D.+D.+Wisnoskiauthor=J.+E.+Thompsonauthor=E.+A.+O%E2%80%99Neillauthor=S.+J.+O%E2%80%99Keefe&title=p38+MAP+kinase+inhibitors.+Part+3%3A+SAR+on+3%2C4-dihydropyrimido%5B4%2C5-d%5Dpyrimidones+and+3%2C4-dihydropyrido%5B4%2C3-d%5Dpyrimidin-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNatarajan%26aufirst%3DS.%2BR.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors.%2520Part%25203%253A%2520SAR%2520on%25203%252C4-dihydropyrimido%255B4%252C5-d%255Dpyrimidones%2520and%25203%252C4-dihydropyrido%255B4%252C3-d%255Dpyrimidin-2-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D16%26spage%3D4400%26epage%3D4404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, N.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors: Many are made, but few are chosen</span> <span class="citation_source-journal">Curr. Opin. Drug Dis. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16022178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=421-430&issue=4&author=C.+Dominguezauthor=D.+A.+Powersauthor=N.+Tamayo&title=p38+MAP+kinase+inhibitors%3A+Many+are+made%2C+but+few+are+chosen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAP kinase inhibitors: Many are made, but few are chosen</span></div><div class="casAuthors">Dominguez, Celia; Powers, David A.; Tamayo, Nuria</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The mitogen-activated protein kinase (MAPK) p38 is a Ser/Thr kinase, originally isolated from lipopolysaccharide-stimulated monocytes.  There are 4 isoforms of the enzyme (p38α, p38β, p38γ and p38δ), which differ in tissue distribution, regulation of kinase activation, and subsequent phosphorylation of downstream substrates.  These enzymes also differ in sensitivity to p38 MAPK inhibitors.  The most thoroughly studied isoform is p38α, for which activation was obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  P38α kinase is involved in the biosynthesis of the cytokines tumor necrosis factor-α and interleukin-1β at the translational and transcriptional level.  MAPK p38α represents a point of convergence for multiple signaling processes that are activated during inflammation, making it a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and a pyridinyl-imidazole-based p38α inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatments for inflammatory diseases.  Herein, a brief overview is provided of the discovery and development of AMG-548 (Amgen Inc), a selective and efficacious p38α inhibitor, and its pharmacodynamic effects in a 1st-in-human study.  Data from a phase I multidose clin. trial are also included.  In addn., other p38α inhibitors that have advanced to clin. trials over the last 3 years are discussed, such as BIRB-796 (Boehringer Ingelheim Pharmaceuticals Inc).  SCIO-469 and SCIO-323 (Scios Inc), and VX-702 (Vertex Pharmaceuticals Inc/Kissei Pharmaceutical Co).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjiFXW2ScCerVg90H21EOLACvtfcHk0liEyn3Apt6HJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7s%253D&md5=d07c0471bc8e02479c0fdd710bfdbb69</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DPowers%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DN.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors%253A%2520Many%2520are%2520made%252C%2520but%2520few%2520are%2520chosen%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Dis.%2520Dev.%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38α protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+kinase+p38+inhibitors%3A+clinical+results+and+an+intimate+look+at+their+interactions+with+p38%CE%B1+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0lg2ZLY4b5_M_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520kinase%2520p38%2520inhibitors%253A%2520clinical%2520results%2520and%2520an%2520intimate%2520look%2520at%2520their%2520interactions%2520with%2520p38%25CE%25B1%2520protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2979%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors: discovery and binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=318-323&issue=1&author=R.+M.+Angellauthor=P.+Bamboroughauthor=A.+Cleasbyauthor=S.+G.+Cockerillauthor=K.+L.+Jonesauthor=C.+J.+Mooneyauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors%3A+discovery+and+binding+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DMooney%26aufirst%3DC.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%253A%2520discovery%2520and%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D318%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, M.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors. 2: Optimization and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=324-328&issue=1&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=D.+Brownauthor=M.+Brownauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=C.+D.+Edwardsauthor=K.+L.+Jonesauthor=T.+Longstaffauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=M.+Willson&title=Biphenyl+amide+p38+kinase+inhibitors.+2%3A+Optimization+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWillson%26aufirst%3DM.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors.%25202%253A%2520Optimization%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Boeck, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors. 3: Improvement of cellular and in vivo activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4428</span><span class="NLM_x">–</span> <span class="NLM_lpage">4432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4428-4432&issue=15&author=R.+M.+Angellauthor=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=S.+J.+de+Boeckauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=S.+Patelauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors.+3%3A+Improvement+of+cellular+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3Dde%2BBoeck%26aufirst%3DS.%2BJ.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors.%25203%253A%2520Improvement%2520of%2520cellular%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4428%26epage%3D4432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludbrook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide 38 kinase inhibitors. 4: DFG-in and DFG-out binding modes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4433-4437&issue=15&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=M.+J.+Bamfordauthor=C.+Chungauthor=S.+G.+Cockerillauthor=S.+S.+Flackauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=T.+Longstaffauthor=S.+Ludbrookauthor=R.+Pearsonauthor=K.+J.+Smithauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+38+kinase+inhibitors.+4%3A+DFG-in+and+DFG-out+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DFlack%26aufirst%3DS.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DLudbrook%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%252038%2520kinase%2520inhibitors.%25204%253A%2520DFG-in%2520and%2520DFG-out%2520binding%2520modes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4433%26epage%3D4437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Schrier, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flory, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, D.K-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. A.</span><span> </span><span class="NLM_article-title">Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=9500524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1OqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=359-363&author=D.+C.+Schrierauthor=R.+C.+Schimmerauthor=C.+M.+Floryauthor=D.K-L.+Tungauthor=P.+A.+Ward&title=Role+of+chemokines+and+cytokines+in+a+reactivation+model+of+arthritis+in+rats+induced+by+injection+with+streptococcal+cell+walls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls</span></div><div class="casAuthors">Schrier, D. J.; Schimmer, R. C.; Flory, C. M.; Tung, D. K. - L.; Ward, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-363</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Intra-articular injection of streptococcal cell wall (SCW) antigen followed by i.v. challenge results in a T cell-mediated monoarticular arthritis in female Lewis rats.  Initial studies showed that this reactivation response to i.v. SCW antigen is dependent on the presence of interleukin-1 (IL-1) and tumor necrosis factor α (TNF-α) and that the early phase of swelling is neutrophil-dependent.  Neutrophil depletion or passive immunization with antibodies to P-selectin or macrophage inflammatory protein-2 reduced the intensity of ankle edema and the influx of neutrophils.  After the first few days, however, the arthritic response is mediated primarily by mononuclear cells.  Joint tissues showed up-regulation of mRNA for monocyte chemotactic protein-1 (MCP-1), which could be inhibited in part by anti-IL-4; treatment of rats with antibodies to IL-4 or MCP-1 significantly suppressed development of ankle edema and histopathol. evidence of inflammation.  Antibodies to interferon-γ or IL-10 had no effect.  Treatment with anti-MCP-1 also suppressed influx of 111In-labeled T cells into the ankle joint.  These data suggest that the late, mononuclear-dependent phase of SCW-induced arthritis in female Lewis rats requires cytokines that up-regulate MCP-1, which in turn may facilitate recruitment and extravasation of mononuclear cells into the joint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVmkq5PnxGrVg90H21EOLACvtfcHk0lj7wf5UzM1bjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs1OqtLg%253D&md5=08f0f15db0d46f7372c745b0f7797967</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchrier%26aufirst%3DD.%2BC.%26aulast%3DSchimmer%26aufirst%3DR.%2BC.%26aulast%3DFlory%26aufirst%3DC.%2BM.%26aulast%3DTung%26aufirst%3DD.K-L.%26aulast%3DWard%26aufirst%3DP.%2BA.%26atitle%3DRole%2520of%2520chemokines%2520and%2520cytokines%2520in%2520a%2520reactivation%2520model%2520of%2520arthritis%2520in%2520rats%2520induced%2520by%2520injection%2520with%2520streptococcal%2520cell%2520walls%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1998%26volume%3D63%26spage%3D359%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Courtenay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayan, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosedale, B.</span><span> </span><span class="NLM_article-title">Immunisation against heterologous type II collagen-induced arthritis in mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">2843</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2843&publication_year=1980&pages=666-668&author=J.+S.+Courtenayauthor=M.+J.+Dallmanauthor=A.+B.+Dayanauthor=A.+Martinauthor=B.+Mosedale&title=Immunisation+against+heterologous+type+II+collagen-induced+arthritis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCourtenay%26aufirst%3DJ.%2BS.%26aulast%3DDallman%26aufirst%3DM.%2BJ.%26aulast%3DDayan%26aufirst%3DA.%2BB.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DMosedale%26aufirst%3DB.%26atitle%3DImmunisation%2520against%2520heterologous%2520type%2520II%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DNature%26date%3D1980%26volume%3D2843%26spage%3D666%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Joosten, L. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsen, M. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Loo, F. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, W. B.</span><span> </span><span class="NLM_article-title">Anticytokine treatment of established collagen-induced arthritis in DBA/1 mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1002%2Fart.1780390513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=8639177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK28XjsValtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=797-809&author=L.+A.+B.+Joostenauthor=M.+M.+A.+Helsenauthor=F.+A.+J.+van+de+Looauthor=W.+B.+van+den+Berg&title=Anticytokine+treatment+of+established+collagen-induced+arthritis+in+DBA%2F1+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra</span></div><div class="casAuthors">Joosten, Leo A. B.; Helsen, Monique M. A.; Van De Loo, Fons A. J.; Van Den Berg, Wim B.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">797-809</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">The authors examd. the role of tumor necrosis factor α (TNF α), interleukin-1α (IL-1α), and IL-1β in collagen-induced arthritis (CIA), immediately after onset and during the phase of established arthritis.  Male DBA/1 mice with collagen-induced arthritis were treated with antibodies against murine TNF α and IL-1α/β at different time points of the disease.  IL-1 receptor antagonist (IL-1Ra) was administered using Alzet osmotic mini-pumps.  The effect of anti-cytokine treatment was monitored by visual scoring.  Histol. and cytokine reverse transcription polymerase chain reaction (RT-PCR) analyses were performed at the end of the treatment period.  Anti-TNF α treatment showed efficacy shortly after onset of the disease, but had little effect on fully established CIA.  Histol. anal. after early treatment revealed that anti-TNF α significantly reduced joint pathol., as detd. by infiltration of inflammatory cells and cartilage damage.  Anti-IL-1α/β treatment ameliorated both early and full-blown CIA.  This clear suppression of established arthritis was confirmed by administration of high doses of IL-1Ra.  Dose-response expts. showed that a continuous supply of 1 mg/day was needed for optimal suppression.  Histol. anal. showed markedly reduced cartilage destruction both in the knee and the ankle joints.  Autoradiog. demonstrated full recovery of chondrocyte synthetic function of articular cartilage.  In addn., the authors found that the IL-1β isoform plays a dominant role in established CIA.  Profound suppression of CIA was obsd. with anti-IL-1β, although elimination of both IL-1α and IL-1β still gave better protection.  Anal. of mRNA with RT-PCR revealed that IL-1β was highly upregulated in synovium and cartilage at late stages of CIA, whereas anti-IL-1β treatment markedly reduced IL-1β message in the synovium.  The present study identified different TNFα/IL-1 dependencies in various stages of CIA and revealed that blocking of TNFα does not necessarily eliminate IL-1.  Continuous, high doses of IL-1Ra are needed to block CIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPs5rv07Iyo7Vg90H21EOLACvtfcHk0lj7wf5UzM1bjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsValtLc%253D&md5=cb86f131237c1b630e0d039215f52d72</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fart.1780390513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780390513%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DHelsen%26aufirst%3DM.%2BM.%2BA.%26aulast%3Dvan%2Bde%2BLoo%26aufirst%3DF.%2BA.%2BJ.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%2BB.%26atitle%3DAnticytokine%2520treatment%2520of%2520established%2520collagen-induced%2520arthritis%2520in%2520DBA%252F1%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D1996%26volume%3D39%26spage%3D797%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Joosten, L. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsen, M. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Loo, F. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinegard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, W. B.</span><span> </span><span class="NLM_article-title">IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen induced arthritis whereas TNF-α blockade only ameliorates joint inflammation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">5049</span><span class="NLM_x">–</span> <span class="NLM_lpage">5055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=5049-5055&author=L.+A.+B.+Joostenauthor=M.+M.+A.+Helsenauthor=T.+Saxneauthor=F.+A.+J.+van+de+Looauthor=D.+Heinegardauthor=W.+B.+van+den+Berg&title=IL-1%CE%B1%CE%B2+blockade+prevents+cartilage+and+bone+destruction+in+murine+type+II+collagen+induced+arthritis+whereas+TNF-%CE%B1+blockade+only+ameliorates+joint+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DHelsen%26aufirst%3DM.%2BM.%2BA.%26aulast%3DSaxne%26aufirst%3DT.%26aulast%3Dvan%2Bde%2BLoo%26aufirst%3DF.%2BA.%2BJ.%26aulast%3DHeinegard%26aufirst%3DD.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%2BB.%26atitle%3DIL-1%25CE%25B1%25CE%25B2%2520blockade%2520prevents%2520cartilage%2520and%2520bone%2520destruction%2520in%2520murine%2520type%2520II%2520collagen%2520induced%2520arthritis%2520whereas%2520TNF-%25CE%25B1%2520blockade%2520only%2520ameliorates%2520joint%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D5049%26epage%3D5055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Williams, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, R. N.</span><span> </span><span class="NLM_article-title">Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">9784</span><span class="NLM_x">–</span> <span class="NLM_lpage">9788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=9784-9788&author=R.+O.+Williamsauthor=M.+Feldmannauthor=R.+N.+Maini&title=Anti-tumor+necrosis+factor+ameliorates+joint+disease+in+murine+collagen-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DAnti-tumor%2520necrosis%2520factor%2520ameliorates%2520joint%2520disease%2520in%2520murine%2520collagen-induced%2520arthritis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1992%26volume%3D89%26spage%3D9784%26epage%3D9788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D.</span><span> </span><span class="NLM_article-title">Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to Log P/log D</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2022</span><span class="NLM_x">–</span> <span class="NLM_lpage">2029</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac961242d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=2022-2029&issue=11&author=K.+Valkoauthor=C.+Bevanauthor=D.+Reynolds&title=Chromatographic+Hydrophobicity+Index+by+Fast-Gradient+RP-HPLC%3A+A+High-Throughput+Alternative+to+Log+P%2Flog+D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fac961242d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac961242d%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DChromatographic%2520Hydrophobicity%2520Index%2520by%2520Fast-Gradient%2520RP-HPLC%253A%2520A%2520High-Throughput%2520Alternative%2520to%2520Log%2520P%252Flog%2520D%26jtitle%3DAnal.%2520Chem.%26date%3D1997%26volume%3D69%26issue%3D11%26spage%3D2022%26epage%3D2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">HSA binding constants were obtained by high performance affinity chromatography on a column of immobilized human serum albumin.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Solubilities were measured either from dissolution of solid into water buffered to pH7.4 or by precipitation from 10 mM DMSO solution.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Edwards, C. D.</span><div class="note"><p class="first last">Drug Metabolism Discussion Group, Sept 2004. Poster included in <a class="ref internalNav" href="#si" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Edwards%2C+C.+D.Drug+Metabolism+Discussion+Group%2C+Sept+2004.+Poster+included+in+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DC.%2BD." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Okada, S.; Kayakiri, N.; Sawaday, Y.; Tanaka, H.; Hashimoto, M.</span><span> </span><span class="NLM_article-title">Indole derivatives</span>. World Patent WO93/03012,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=S.+Okada&author=N.+Kayakiri&author=Y.+Sawaday&author=H.+Tanaka&author=M.+Hashimoto&title=Indole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DS.%26atitle%3DIndole%2520derivatives%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Schlosser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geneste, H.</span><span> </span><span class="NLM_article-title">The super base approach to flurbiprofen: an exercise in optionally site-selective metalation</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1969</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1002%2F%28SICI%291521-3765%2819981002%294%3A10%3C1969%3A%3AAID-CHEM1969%3E3.0.CO%3B2-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVOmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1969-1973&issue=10&author=M.+Schlosserauthor=H.+Geneste&title=The+super+base+approach+to+flurbiprofen%3A+an+exercise+in+optionally+site-selective+metalation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The super base approach to flurbiprofen: an exercise in optionally site-selective metalation</span></div><div class="casAuthors">Schlosser, Manfred; Geneste, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry--A European Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1969-1973</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A superior route to the analgesic flurbiprofen has been devised.  Key steps are the selective deprotonation of 3-fluorotoluene with tert-butyllithium in the presence of potassium tert-butoxide (LIT-KOR) at the 4-position and the selective deprotonation of the 4-methyl-2-fluorobiphenyl with lithium diisopropylamide in the presence of potassium tert-butoxide (LIDA-KOR) at the benzylic position.  Depending on the reagent and the substituent pattern, the 3- and 5-positions of 2-fluorobiphenyls can also be specifically attacked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDD_bH5W5xXrVg90H21EOLACvtfcHk0ljzyKY-j0km9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVOmt7g%253D&md5=b1166369fe27e66e51b3a5bd14203c89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2819981002%294%3A10%3C1969%3A%3AAID-CHEM1969%3E3.0.CO%3B2-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252819981002%25294%253A10%253C1969%253A%253AAID-CHEM1969%253E3.0.CO%253B2-O%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosser%26aufirst%3DM.%26aulast%3DGeneste%26aufirst%3DH.%26atitle%3DThe%2520super%2520base%2520approach%2520to%2520flurbiprofen%253A%2520an%2520exercise%2520in%2520optionally%2520site-selective%2520metalation%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D1998%26volume%3D4%26issue%3D10%26spage%3D1969%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>.  <span class="citation_source-book">Macromolecular Crystallography, Part A</span>; <span class="NLM_series">Methods in Enzymology, Vol. 276</span>; <span class="NLM_contrib-group">Carter, C.W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.W.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%26aulast%3DCarter%26aufirst%3DC.W.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Collaborative Computational Project Number 4</span><span> </span><span class="NLM_article-title">The CCP4 Suite: Programs for Protein Crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&issue=5&author=Collaborative+Computational+Project+Number+4&title=The+CCP4+Suite%3A+Programs+for+Protein+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520Suite%253A%2520Programs%2520for%2520Protein%2520Crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26issue%3D5%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&issue=5&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26issue%3D5%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':[],'ref21':[],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John G.  Cumming</span>, <span class="hlFld-ContribAuthor ">Judit É.  Debreczeni</span>, <span class="hlFld-ContribAuthor ">Fredrik  Edfeldt</span>, <span class="hlFld-ContribAuthor ">Emma  Evertsson</span>, <span class="hlFld-ContribAuthor ">Martin  Harrison</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Michael J.  James</span>, <span class="hlFld-ContribAuthor ">Scott G.  Lamont</span>, <span class="hlFld-ContribAuthor ">Keith  Oldham</span>, <span class="hlFld-ContribAuthor ">Jane E.  Sullivan</span>, and <span class="hlFld-ContribAuthor ">Stuart L.  Wells</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 278-293. <a href="https://doi.org/10.1021/jm501038s" title="DOI URL">https://doi.org/10.1021/jm501038s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501038s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501038s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BMAPK-activated%252BProtein%252BKinase-2%252BPrevention%252Bof%252BActivation%252BInhibitors%26aulast%3DCumming%26aufirst%3DJohn%2BG.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D10072014%26date%3D09102014%26date%3D08012015%26date%3D25092014%26volume%3D58%26issue%3D1%26spage%3D278%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Pettus</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">Bradley  Henkle</span>, <span class="hlFld-ContribAuthor ">Helen J.  McBride</span>, <span class="hlFld-ContribAuthor ">Christiaan J. M.  Saris</span>, <span class="hlFld-ContribAuthor ">Lu Min  Wong</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Plant</span>, <span class="hlFld-ContribAuthor ">Lisa  Sherman</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span> and <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyridazinopyridinones as Potent and Selective p38 Mitogen-Activated Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (17)
                                     , 6398-6411. <a href="https://doi.org/10.1021/jm100567y" title="DOI URL">https://doi.org/10.1021/jm100567y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100567y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100567y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyridazinopyridinones%252Bas%252BPotent%252Band%252BSelective%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252BInhibitors%26aulast%3DWu%26aufirst%3DBin%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10052010%26date%3D16082010%26date%3D09092010%26volume%3D53%26issue%3D17%26spage%3D6398%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Shimin  Xu</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Bradley  Henkle</span>, <span class="hlFld-ContribAuthor ">Qiurong  Liu</span>, <span class="hlFld-ContribAuthor ">Helen J.  McBride</span>, <span class="hlFld-ContribAuthor ">Sharon  Mu</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Plant</span>, <span class="hlFld-ContribAuthor ">Christiaan J. M.  Saris</span>, <span class="hlFld-ContribAuthor ">Lisa  Sherman</span>, <span class="hlFld-ContribAuthor ">Lu Min  Wong</span>, <span class="hlFld-ContribAuthor ">Samer  Chmait</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span> and <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase⊥Atomic coordinates and structure factors for crystal structure of compound 3d with p38α can be accessed using PDB code 3LHJ.. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (7)
                                     , 2973-2985. <a href="https://doi.org/10.1021/jm100095x" title="DOI URL">https://doi.org/10.1021/jm100095x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100095x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100095x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEvaluation%252Bof%252B7-Alkyl-1%25252C5-bis-aryl-pyrazolopyridinones%252Bas%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BInhibitors%252Bof%252Bp38%2525CE%2525B1%252BMitogen-Activated%252BProtein%252BKinase%2525E2%25258A%2525A5Atomic%252Bcoordinates%252Band%252Bstructure%252Bfactors%252Bfor%252Bcrystal%252Bstructure%252Bof%252Bcompound%252B3d%252Bwith%252Bp38%2525CE%2525B1%252Bcan%252Bbe%252Baccessed%252Busing%252BPDB%252Bcode%252B3LHJ.%26aulast%3DPettus%26aufirst%3DLiping%2BH.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D22012010%26date%3D10032010%26date%3D08042010%26volume%3D53%26issue%3D7%26spage%3D2973%26epage%3D2985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Yan  Lou</span> and <span class="hlFld-ContribAuthor ">Michael J.  Soth</span>. </span><span class="cited-content_cbyCitation_article-title">Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (6)
                                     , 2345-2353. <a href="https://doi.org/10.1021/jm9012906" title="DOI URL">https://doi.org/10.1021/jm9012906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9012906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9012906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Bp38%2525CE%2525B1%252BInhibitors%252BClinically%252BEvaluated%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BInflammatory%252BDisorders%26aulast%3DGoldstein%26aufirst%3DDavid%2BM.%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D27082009%26date%3D01122009%26date%3D25032010%26volume%3D53%26issue%3D6%26spage%3D2345%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa M.  Madkour</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>. </span><span class="cited-content_cbyCitation_article-title">Current status and future prospects of p38α/MAPK14 kinase and its inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113216. <a href="https://doi.org/10.1016/j.ejmech.2021.113216" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113216%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Bstatus%252Band%252Bfuture%252Bprospects%252Bof%252Bp38%2525CE%2525B1%25252FMAPK14%252Bkinase%252Band%252Bits%252Binhibitors%26aulast%3DMadkour%26aufirst%3DMoustafa%2BM.%26date%3D2021%26volume%3D213%26spage%3D113216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Kaieda</span>, <span class="hlFld-ContribAuthor ">Masashi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hiromi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Rei  Okamoto</span>, <span class="hlFld-ContribAuthor ">Shinji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Masayuki  Gotoh</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yuri  Hori</span>, <span class="hlFld-ContribAuthor ">Satoko  Unno</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiko  Itono</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Kengo  Okada</span>, <span class="hlFld-ContribAuthor ">Weston  Lane</span>, <span class="hlFld-ContribAuthor ">Bi‐Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Kumar  Saikatendu</span>, <span class="hlFld-ContribAuthor ">Shinichiro  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Seiji  Miwatashi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5‐
              b
              ]Pyridin‐2‐one‐Based p38 MAP Kinase Inhibitors: Part 2. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (24)
                                     , 2093-2101. <a href="https://doi.org/10.1002/cmdc.201900373" title="DOI URL">https://doi.org/10.1002/cmdc.201900373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900373%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252590Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BImidazo%25255B4%25252C5%2525E2%252580%252590%252Bb%252B%25255DPyridin%2525E2%252580%2525902%2525E2%252580%252590one%2525E2%252580%252590Based%252Bp38%252BMAP%252BKinase%252BInhibitors%25253A%252BPart%2525E2%252580%2525852%26aulast%3DKaieda%26aufirst%3DAkira%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D24%26spage%3D2093%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulf  Hedström</span>, <span class="hlFld-ContribAuthor ">Monica  Norberg</span>, <span class="hlFld-ContribAuthor ">Emma  Evertsson</span>, <span class="hlFld-ContribAuthor ">Sarah R.  Lever</span>, <span class="hlFld-ContribAuthor ">Magnus  Munck af Rosenschöld</span>, <span class="hlFld-ContribAuthor ">Hans  Lönn</span>, <span class="hlFld-ContribAuthor ">Peter  Bold</span>, <span class="hlFld-ContribAuthor ">Helena  Käck</span>, <span class="hlFld-ContribAuthor ">Pia  Berntsson</span>, <span class="hlFld-ContribAuthor ">Johanna  Vinblad</span>, <span class="hlFld-ContribAuthor ">Jianming  Liu</span>, <span class="hlFld-ContribAuthor ">Anette  Welinder</span>, <span class="hlFld-ContribAuthor ">Johan  Karlsson</span>, <span class="hlFld-ContribAuthor ">Arjan  Snijder</span>, <span class="hlFld-ContribAuthor ">Katerina  Pardali</span>, <span class="hlFld-ContribAuthor ">Ulf  Andersson</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Davis</span>, <span class="hlFld-ContribAuthor ">Mickael  Mogemark</span>. </span><span class="cited-content_cbyCitation_article-title">An Angle on MK2 Inhibition—Optimization and Evaluation of Prevention of Activation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (19)
                                     , 1701-1709. <a href="https://doi.org/10.1002/cmdc.201900303" title="DOI URL">https://doi.org/10.1002/cmdc.201900303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900303%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAn%252BAngle%252Bon%252BMK2%252BInhibition%2525E2%252580%252594Optimization%252Band%252BEvaluation%252Bof%252BPrevention%252Bof%252BActivation%252BInhibitors%26aulast%3DHedstr%25C3%25B6m%26aufirst%3DUlf%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D19%26spage%3D1701%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming‐Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Jérôme  Waser</span>. </span><span class="cited-content_cbyCitation_article-title">1,3‐Difunctionalization of Aminocyclopropanes via Dielectrophilic Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (39)
                                     , 14018-14022. <a href="https://doi.org/10.1002/ange.201907060" title="DOI URL">https://doi.org/10.1002/ange.201907060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201907060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201907060%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3D1%25252C3%2525E2%252580%252590Difunctionalization%252Bof%252BAminocyclopropanes%252Bvia%252BDielectrophilic%252BIntermediates%26aulast%3DWang%26aufirst%3DMing%25E2%2580%2590Ming%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D39%26spage%3D14018%26epage%3D14022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming‐Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Jérôme  Waser</span>. </span><span class="cited-content_cbyCitation_article-title">1,3‐Difunctionalization of Aminocyclopropanes via Dielectrophilic Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (39)
                                     , 13880-13884. <a href="https://doi.org/10.1002/anie.201907060" title="DOI URL">https://doi.org/10.1002/anie.201907060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201907060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201907060%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3D1%25252C3%2525E2%252580%252590Difunctionalization%252Bof%252BAminocyclopropanes%252Bvia%252BDielectrophilic%252BIntermediates%26aulast%3DWang%26aufirst%3DMing%25E2%2580%2590Ming%26date%3D2019%26volume%3D58%26issue%3D39%26spage%3D13880%26epage%3D13884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Xing</span>, <span class="hlFld-ContribAuthor ">J.  Mathias</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Case History: Structure-Based Drug Design of Oral and Inhaled p38 MAP Kinase Inhibitors as Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-430. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12458-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12458-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12458-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12458-8%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252BCase%252BHistory%25253A%252BStructure-Based%252BDrug%252BDesign%252Bof%252BOral%252Band%252BInhaled%252Bp38%252BMAP%252BKinase%252BInhibitors%252Bas%252BClinical%252BCandidates%26aulast%3DXing%26aufirst%3DL.%26date%3D2017%26spage%3D408%26epage%3D430%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baljinder K  Bains</span>, <span class="hlFld-ContribAuthor ">Michelle K  Greene</span>, <span class="hlFld-ContribAuthor ">Leona M  McGirr</span>, <span class="hlFld-ContribAuthor ">Jay  Dorman</span>, <span class="hlFld-ContribAuthor ">Stuart N  Farrow</span>, <span class="hlFld-ContribAuthor ">Christopher J  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Encapsulation of the p38 MAPK inhibitor GSK 678361A in nanoparticles for inflammatory-based disease states. </span><span class="cited-content_cbyCitation_journal-name">Journal of Interdisciplinary Nanomedicine</span><span> <strong>2016,</strong> <em>1 </em>
                                    (3)
                                     , 85-92. <a href="https://doi.org/10.1002/jin2.9" title="DOI URL">https://doi.org/10.1002/jin2.9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jin2.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjin2.9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Interdisciplinary%2520Nanomedicine%26atitle%3DEncapsulation%252Bof%252Bthe%252Bp38%252BMAPK%252Binhibitor%252BGSK%252B678361A%252Bin%252Bnanoparticles%252Bfor%252Binflammatory-based%252Bdisease%252Bstates%26aulast%3DBains%26aufirst%3DBaljinder%2BK%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D3%26spage%3D85%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyuk  Heo</span>, <span class="hlFld-ContribAuthor ">Hanbo  Shin</span>, <span class="hlFld-ContribAuthor ">Jun  Lee</span>, <span class="hlFld-ContribAuthor ">Taelim  Kim</span>, <span class="hlFld-ContribAuthor ">Kyung-Soo  Inn</span>, <span class="hlFld-ContribAuthor ">Nam-Jung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3694-3698. <a href="https://doi.org/10.1016/j.bmcl.2015.06.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-cyclopropylbenzamide-benzophenone%252Bhybrids%252Bas%252Bnovel%252Band%252Bselective%252Bp38%252Bmitogen%252Bactivated%252Bprotein%252Bkinase%252B%252528MAPK%252529%252Binhibitors%26aulast%3DHeo%26aufirst%3DJinyuk%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3694%26epage%3D3698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thor  Ostenfeld</span>, <span class="hlFld-ContribAuthor ">Alok  Krishen</span>, <span class="hlFld-ContribAuthor ">Robert Y.  Lai</span>, <span class="hlFld-ContribAuthor ">Jonathan  Bullman</span>, <span class="hlFld-ContribAuthor ">Joanne  Green</span>, <span class="hlFld-ContribAuthor ">Praveen  Anand</span>, <span class="hlFld-ContribAuthor ">Joachim  Scholz</span>, <span class="hlFld-ContribAuthor ">Madeline  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy. </span><span class="cited-content_cbyCitation_journal-name">The Clinical Journal of Pain</span><span> <strong>2015,</strong> <em>31 </em>
                                    (4)
                                     , 283-293. <a href="https://doi.org/10.1097/AJP.0000000000000122" title="DOI URL">https://doi.org/10.1097/AJP.0000000000000122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/AJP.0000000000000122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FAJP.0000000000000122%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Clinical%2520Journal%2520of%2520Pain%26atitle%3DA%252BRandomized%25252C%252BPlacebo-controlled%252BTrial%252Bof%252Bthe%252BAnalgesic%252BEfficacy%252Band%252BSafety%252Bof%252Bthe%252Bp38%252BMAP%252BKinase%252BInhibitor%25252C%252BLosmapimod%25252C%252Bin%252BPatients%252BWith%252BNeuropathic%252BPain%252BFrom%252BLumbosacral%252BRadiculopathy%26aulast%3DOstenfeld%26aufirst%3DThor%26date%3D2015%26volume%3D31%26issue%3D4%26spage%3D283%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2015,</strong> <em>24 </em>
                                    (3)
                                     , 383-392. <a href="https://doi.org/10.1517/13543784.2015.1006358" title="DOI URL">https://doi.org/10.1517/13543784.2015.1006358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2015.1006358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2015.1006358%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bp38%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D3%26spage%3D383%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dramane  Lainé</span>, <span class="hlFld-ContribAuthor ">Matthew  Lucas</span>, <span class="hlFld-ContribAuthor ">Francisco  Lopez-Tapia</span>, <span class="hlFld-ContribAuthor ">Stephen  Lynch</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Kinases in Asthma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 255-288. <a href="https://doi.org/10.1002/9783527677252.ch11" title="DOI URL">https://doi.org/10.1002/9783527677252.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677252.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677252.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BPotential%252Bof%252BKinases%252Bin%252BAsthma%26aulast%3DLain%25C3%25A9%26aufirst%3DDramane%26date%3D2013%26date%3D2013%26spage%3D255%26epage%3D288%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BPersonalized%252BMedicine%26aulast%3DLackey%26aufirst%3DKaren%26date%3D2013%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuying  Yang</span>, <span class="hlFld-ContribAuthor ">Pauline  Lukey</span>, <span class="hlFld-ContribAuthor ">Misba  Beerahee</span>, <span class="hlFld-ContribAuthor ">Frank  Hoke</span>. </span><span class="cited-content_cbyCitation_article-title">Population Pharmacokinetics of Losmapimod in Healthy Subjects and Patients with Rheumatoid Arthritis and Chronic Obstructive Pulmonary Diseases. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2013,</strong> <em>52 </em>
                                    (3)
                                     , 187-198. <a href="https://doi.org/10.1007/s40262-012-0025-6" title="DOI URL">https://doi.org/10.1007/s40262-012-0025-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-012-0025-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-012-0025-6%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DPopulation%252BPharmacokinetics%252Bof%252BLosmapimod%252Bin%252BHealthy%252BSubjects%252Band%252BPatients%252Bwith%252BRheumatoid%252BArthritis%252Band%252BChronic%252BObstructive%252BPulmonary%252BDiseases%26aulast%3DYang%26aufirst%3DShuying%26date%3D2013%26date%3D2012%26volume%3D52%26issue%3D3%26spage%3D187%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verica  Paunovic</span>, <span class="hlFld-ContribAuthor ">Margaret M.  Harnett</span>. </span><span class="cited-content_cbyCitation_article-title">Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2013,</strong> <em>73 </em>
                                    (2)
                                     , 101-115. <a href="https://doi.org/10.1007/s40265-013-0014-6" title="DOI URL">https://doi.org/10.1007/s40265-013-0014-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-013-0014-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-013-0014-6%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DMitogen-Activated%252BProtein%252BKinases%252Bas%252BTherapeutic%252BTargets%252Bfor%252BRheumatoid%252BArthritis%26aulast%3DPaunovic%26aufirst%3DVerica%26date%3D2013%26date%3D2013%26volume%3D73%26issue%3D2%26spage%3D101%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Bamborough</span>. </span><span class="cited-content_cbyCitation_article-title">System-based drug discovery within the human kinome. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2012,</strong> <em>7 </em>
                                    (11)
                                     , 1053-1070. <a href="https://doi.org/10.1517/17460441.2012.724056" title="DOI URL">https://doi.org/10.1517/17460441.2012.724056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2012.724056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2012.724056%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DSystem-based%252Bdrug%252Bdiscovery%252Bwithin%252Bthe%252Bhuman%252Bkinome%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D11%26spage%3D1053%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dearg S.  Brown</span>, <span class="hlFld-ContribAuthor ">John G.  Cumming</span>, <span class="hlFld-ContribAuthor ">Paul  Bethel</span>, <span class="hlFld-ContribAuthor ">Jonathan  Finlayson</span>, <span class="hlFld-ContribAuthor ">Stefan  Gerhardt</span>, <span class="hlFld-ContribAuthor ">Ian  Nash</span>, <span class="hlFld-ContribAuthor ">Richard A.  Pauptit</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Alan  Reid</span>, <span class="hlFld-ContribAuthor ">Wendy  Snelson</span>, <span class="hlFld-ContribAuthor ">Steve  Swallow</span>, <span class="hlFld-ContribAuthor ">Caroline  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 3879-3883. <a href="https://doi.org/10.1016/j.bmcl.2012.04.116" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.116%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252BN-cyclopropyl-4-methyl-3-%25255B6-%2525284-methylpiperazin-1-yl%252529-4-oxoquinazolin-3%2525284H%252529-yl%25255Dbenzamide%252B%252528AZD6703%252529%25252C%252Ba%252Bclinical%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DBrown%26aufirst%3DDearg%2BS.%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D3879%26epage%3D3883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie B.  Vinh</span>, <span class="hlFld-ContribAuthor ">Jamie S.  Simpson</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">David K.  Chalmers</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2012,</strong> <em>26 </em>
                                    (4)
                                     , 409-423. <a href="https://doi.org/10.1007/s10822-012-9569-7" title="DOI URL">https://doi.org/10.1007/s10822-012-9569-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-012-9569-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-012-9569-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DVirtual%252Bscreening%252Busing%252Ba%252Bconformationally%252Bflexible%252Btarget%252Bprotein%25253A%252Bmodels%252Bfor%252Bligand%252Bbinding%252Bto%252Bp38%2525CE%2525B1%252BMAPK%26aulast%3DVinh%26aufirst%3DNatalie%2BB.%26date%3D2012%26date%3D2012%26volume%3D26%26issue%3D4%26spage%3D409%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Claire  Jackson</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Lisa  Sherman</span>, <span class="hlFld-ContribAuthor ">Qiurong  Liu</span>, <span class="hlFld-ContribAuthor ">Bradley  Henkle</span>, <span class="hlFld-ContribAuthor ">Christiaan J.M.  Saris</span>, <span class="hlFld-ContribAuthor ">Lu Min  Wong</span>, <span class="hlFld-ContribAuthor ">Samer  Chmait</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher  Mohr</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of triazolopyridazinones as potent p38α inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (2)
                                     , 1226-1229. <a href="https://doi.org/10.1016/j.bmcl.2011.11.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Btriazolopyridazinones%252Bas%252Bpotent%252Bp38%2525CE%2525B1%252Binhibitors%26aulast%3DHerberich%26aufirst%3DBrad%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D1226%26epage%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pauline T.  Lukey</span>, <span class="hlFld-ContribAuthor ">Hayley C.  Perry</span>, <span class="hlFld-ContribAuthor ">Shuying  Yang</span>, <span class="hlFld-ContribAuthor ">Simon  Parry</span>, <span class="hlFld-ContribAuthor ">Marion C.  Dickson</span>, <span class="hlFld-ContribAuthor ">Virginia H.  Norris</span>, <span class="hlFld-ContribAuthor ">Paul G.  Russell</span>, <span class="hlFld-ContribAuthor ">Marie  Watissée</span>, <span class="hlFld-ContribAuthor ">Inmaculada  Rioja</span>, <span class="hlFld-ContribAuthor ">Keith P.  Ray</span>, <span class="hlFld-ContribAuthor ">Scott  Crowe</span>, <span class="hlFld-ContribAuthor ">Michael  Binks</span>. </span><span class="cited-content_cbyCitation_article-title">Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA). </span><span class="cited-content_cbyCitation_journal-name">Open Journal of Immunology</span><span> <strong>2012,</strong> <em>02 </em>
                                    (03)
                                     , 85-97. <a href="https://doi.org/10.4236/oji.2012.23011" title="DOI URL">https://doi.org/10.4236/oji.2012.23011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/oji.2012.23011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Foji.2012.23011%26sid%3Dliteratum%253Aachs%26jtitle%3DOpen%2520Journal%2520of%2520Immunology%26atitle%3DSingle%252Bdoses%252Bof%252Bp38%252BMAP%252Bkinase%252Binhibitors%252Bor%252Bprednisolone%252Baffect%252BCRP%252Band%252BIL-6%252Bin%252Bpatients%252Bwith%252Bactive%252BRheumatoid%252BArthritis%252B%252528RA%252529%26aulast%3DLukey%26aufirst%3DPauline%2BT.%26date%3D2012%26volume%3D02%26issue%3D03%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Fischer</span>, <span class="hlFld-ContribAuthor ">Solveigh C  Koeberle</span>, <span class="hlFld-ContribAuthor ">Stefan A  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2011,</strong> <em>21 </em>
                                    (12)
                                     , 1843-1866. <a href="https://doi.org/10.1517/13543776.2011.636737" title="DOI URL">https://doi.org/10.1517/13543776.2011.636737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2011.636737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2011.636737%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%252Binhibitors%25252C%252Ba%252Bpatent%252Breview%252B%2525282005%252B%2525E2%252580%252593%252B2011%252529%26aulast%3DFischer%26aufirst%3DStefan%26date%3D2011%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D1843%26epage%3D1866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (3)
                                     , 309-337. <a href="https://doi.org/10.4155/fmc.10.294" title="DOI URL">https://doi.org/10.4155/fmc.10.294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.10.294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.10.294%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BDFG-in%252Bkinase%252Bconformation%25253A%252Ba%252Bnew%252Btrend%252Bemerging%252Bfrom%252Ba%252Bpatent%252Banalysis%26aulast%3DAngiolini%26aufirst%3DMauro%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D309%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based drug discovery and protein targets in the CNS. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2011,</strong> <em>60 </em>
                                    (1)
                                     , 7-23. <a href="https://doi.org/10.1016/j.neuropharm.2010.07.016" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2010.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2010.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2010.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DStructure-based%252Bdrug%252Bdiscovery%252Band%252Bprotein%252Btargets%252Bin%252Bthe%252BCNS%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2011%26volume%3D60%26issue%3D1%26spage%3D7%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth  Down</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Catherine  Alder</span>, <span class="hlFld-ContribAuthor ">Amanda  Campbell</span>, <span class="hlFld-ContribAuthor ">John A.  Christopher</span>, <span class="hlFld-ContribAuthor ">Maria  Gerelle</span>, <span class="hlFld-ContribAuthor ">Steve  Ludbrook</span>, <span class="hlFld-ContribAuthor ">Dave  Mallett</span>, <span class="hlFld-ContribAuthor ">Geoff  Mellor</span>, <span class="hlFld-ContribAuthor ">David D.  Miller</span>, <span class="hlFld-ContribAuthor ">Rosannah  Pearson</span>, <span class="hlFld-ContribAuthor ">Keith  Ray</span>, <span class="hlFld-ContribAuthor ">Yemisi  Solanke</span>, <span class="hlFld-ContribAuthor ">Don  Somers</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38α MAP kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (13)
                                     , 3936-3940. <a href="https://doi.org/10.1016/j.bmcl.2010.05.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Binitial%252Boptimisation%252Bof%252Bpyrrole-2-carboxamides%252Bas%252Binhibitors%252Bof%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%26aulast%3DDown%26aufirst%3DKenneth%26date%3D2010%26volume%3D20%26issue%3D13%26spage%3D3936%26epage%3D3940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0017.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead molecule <b>1</b> and clinical candidate <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>3</b> bound to p38α showing the fluorine binding in a small pocket formed by Leu 104 and Lys 53.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>11</b> bound to p38α showing interaction of pyridine with network of conserved water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures <b>11</b>−<b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compounds <b>2</b> and <b>13</b> dosed orally twice daily on inflammation in the PG-PS reactivation arthritis model assessed by reduction in measured ankle swelling (mm). A comparison with prednisolone dosed at 2.0 mg/kg once daily is shown. * = <i>p</i> < 0.05 (Anova with posthoc planned comparisons, treatment vs control). ** = <i>p</i> < 0.01 (Anova with posthoc planned comparisons, treatment vs control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compound <b>2</b> on pain in the PG-PS reactivation arthritis model assessed by weight bearing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibition of clinical score in the murine CIA model following 14 days of dosing with <b>2</b> (po bid), compared with prednisolone (3 mg/kg po once daily). * = <i>p</i> < 0.05 (Anova with posthoc planned comparisons, treatment vs control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Biphenylamide Synthesis</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Compounds <b>3</b>−<b>6</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) Br<sub>2</sub>, Fe powder, rt (exothermic); (ii) SOCl<sub>2</sub>, reflux; (iii) cyclopropylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM, rt; (iv) cyclopropylmethylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM, rt; (v) bispinnacolatodiboran, Pd(dppf)Cl<sub>2</sub>, KOAc, DMF, 80 °C; (vi) (Ph<sub>3</sub>P)<sub>4</sub>Pd, 1 M NaHCO<sub>3</sub>, IPA, 80 °C.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. 4-Amide Array Chemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) NIS, trifluoromethylsulfonic acid, −20 °C; (ii) SOCl<sub>2</sub> then cyclopropylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM; (iii) {4-[(methyloxy)carbonyl]phenyl}boronic acid, (Ph<sub>3</sub>P)<sub>4</sub>Pd, 1 M NaHCO<sub>3</sub>, IPA, 80 °C; (iv) 2 M NaOH, MeOH; (v) RNH<sub>2</sub>, HATU, DIPEA, DMF/DCM, rt.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Fluorinated Boronate Ester/Boronic Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) bispinnacolatodiboran, Pd(dppf)Cl<sub>2</sub>, KOAc, DMF, 80 °C; (ii) NaH, <i>n</i>-BuLi, (iPrO)<sub>3</sub>B, THF, −75 °C.</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/medium/jm-2009-004779_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Pyridine Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-20/jm9004779/production/images/large/jm-2009-004779_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9004779&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) SOCl<sub>2</sub> 80 °C; (ii) cyclopropylmethylamine, Na<sub>2</sub>CO<sub>3</sub>, DCM rt; (iii) <b>25b</b>, (Ph<sub>3</sub>P)<sub>4</sub>Pd, 1 M NaHCO<sub>3</sub>, DMF, 90 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Taylor, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, R. N.</span><span> </span><span class="NLM_article-title">Immunotherapy for rheumatoid arthritis</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1016%2FS0952-7915%2800%2900269-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=11544014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFagtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=611-616&issue=5&author=P.+C.+Taylorauthor=R.+O.+Williamsauthor=R.+N.+Maini&title=Immunotherapy+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy for rheumatoid arthritis</span></div><div class="casAuthors">Taylor, P. C.; Williams, R. O.; Maini, R. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">611-616</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Recently published studies confirm that the long-term use of biol. agents targeting TNF-α in therapy for rheumatoid arthritis (RA) gives rise to sustained improvement in symptoms and signs of disease, and in the quality of life.  Furthermore, it has emerged that anti-TNF therapy protects joints from structural damage, which unexpectedly is also obsd. in the patient population showing no apparent benefit in control of signs and symptoms.  Therapeutic benefit is obsd. in established disease that is unresponsive to conventional DMARDS and in early DMARDS-naive RA patients.  Thus, for patients with RA, anti-TNF therapies set a new std. for symptom control and joint protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrubiHzYbnjLbVg90H21EOLACvtfcHk0lja2_awwxG91Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFagtro%253D&md5=a0f5dc2aad455a2a3db1f6e69334da61</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2800%2900269-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252800%252900269-7%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%2BC.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DImmunotherapy%2520for%2520rheumatoid%2520arthritis%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2001%26volume%3D13%26issue%3D5%26spage%3D611%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laydon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenthal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heys, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvatter, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemens, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">A protein kinase involved in the regulation of inflammatory cytokine biosynthesis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=739-746&author=J.+C.+Leeauthor=J.+T.+Laydonauthor=P.+C.+McDonnellauthor=T.+F.+Gallagherauthor=S.+Kumarauthor=D.+Greenauthor=D.+McNultyauthor=M.+J.+Blumenthalauthor=J.+R.+Heysauthor=S.+W.+Landvatterauthor=J.+E.+Stricklerauthor=M.+M.+McLaughlinauthor=I.+R.+Siemensauthor=S.+M.+Fisherauthor=G.+P.+Liviauthor=J.+R.+Whiteauthor=J.+L.+Adamsauthor=P.+R.+Young&title=A+protein+kinase+involved+in+the+regulation+of+inflammatory+cytokine+biosynthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLaydon%26aufirst%3DJ.%2BT.%26aulast%3DMcDonnell%26aufirst%3DP.%2BC.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DMcNulty%26aufirst%3DD.%26aulast%3DBlumenthal%26aufirst%3DM.%2BJ.%26aulast%3DHeys%26aufirst%3DJ.%2BR.%26aulast%3DLandvatter%26aufirst%3DS.%2BW.%26aulast%3DStrickler%26aufirst%3DJ.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DSiemens%26aufirst%3DI.%2BR.%26aulast%3DFisher%26aufirst%3DS.%2BM.%26aulast%3DLivi%26aufirst%3DG.%2BP.%26aulast%3DWhite%26aufirst%3DJ.%2BR.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DA%2520protein%2520kinase%2520involved%2520in%2520the%2520regulation%2520of%2520inflammatory%2520cytokine%2520biosynthesis%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D739%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span> </span><span class="NLM_article-title">p38 MAPK signalling cascades in inflammatory disease</span> <span class="citation_source-journal">Mol. Med. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1016%2FS1357-4310%2899%2901544-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=10498912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=439-447&author=E.+Herlaarauthor=Z.+Brown&title=p38+MAPK+signalling+cascades+in+inflammatory+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAPK signalling cascades in inflammatory disease</span></div><div class="casAuthors">Herlaar, E.; Brown, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Today</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">439-447</span>CODEN:
                <span class="NLM_cas:coden">MMTOFK</span>;
        ISSN:<span class="NLM_cas:issn">1357-4310</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 44 refs.  Inflammatory mediators released during acute and chronic diseases activate multiple intracellular signaling cascades including the mitogen-activated protein kinase (MAPK) signal transduction pathway, which plays a significant role in the recruitment of leukocytes to sites of inflammation.  Stimulation of leukocytes by pro-inflammatory cytokines is known to result in the activation of the MAPK isoform p38.  However, the functional consequences of p38 MAPK activation during leukocyte recruitment, including adhesion, migration and effector functions such as oxidative burst and degranulation, are only just beginning to be elucidated.  Specific p38 inhibitors aimed at reducing the prodn. of inflammatory mediators are now being developed, and might in the future provide more effective treatment for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIhoJ67g0sRrVg90H21EOLACvtfcHk0lhc6cUhOn6RLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVWiu7g%253D&md5=3bf8c8ba39b01b5a3188d75b06107709</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1357-4310%2899%2901544-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-4310%252899%252901544-0%26sid%3Dliteratum%253Aachs%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DZ.%26atitle%3Dp38%2520MAPK%2520signalling%2520cascades%2520in%2520inflammatory%2520disease%26jtitle%3DMol.%2520Med.%2520Today%26date%3D1999%26volume%3D5%26spage%3D439%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">New approaches to the treatment of inflammatory disorders small molecules inhibitors of p38 MAP kinase (Review)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.2174%2F156802606775270323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16454763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVantrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=113-149&author=C.+Peiferauthor=G.+Wagnerauthor=S.+Laufer&title=New+approaches+to+the+treatment+of+inflammatory+disorders+small+molecules+inhibitors+of+p38+MAP+kinase+%28Review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase</span></div><div class="casAuthors">Peifer, Christian; Wagner, Gerd; Laufer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-149</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapy of chronic inflammatory diseases like rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) has recently been enriched by the successful launch of the anti-cytokine biologicals Etanercept [tumor necrosis factor (TNF) receptor-p75 Fc fusion protein], Infliximab (chimeric anti-human TNF-α monoclonal antibody), Adalimumab (recombinant human anti-human TNF-α monoclonal antibody), and Anakinra [recombinant form of human interleukin 1β (IL-1) receptor antagonist].  The success of these novel treatments has impressively demonstrated the clin. benefit that can be gained from therapeutic intervention in cytokine signaling, highlighting the central role of proinflammatory cytokine systems like IL-1β and TNF-α to be validated targets.  However, all of the anti-cytokine biologicals available to date are proteins, and therefore suffering to a varying degree from the general disadvantages assocd. with protein drugs.  Therefore, small mol., orally active anti-cytokine agents, which target specific pathways of proinflammatory cytokines, would offer an attractive to anti-cytokine biologicals.  A no. of mol. targets have been identified for the development of such small mol. agents but p38 mitogen-activated protein (MAP) kinase occupies a central role in the regulation of IL-1β and TNF-α signaling network at both the transcriptional and translational level.  Since the mid-1990s, an immense no. of inhibitors of p38 MAP kinase has been characterized in vitro, and to date several compds. have been advanced into clin. trials.  This review will highlight the correlation between effective inhibition of p38 MAP kinase at the mol. target and cellular activity in functional assays of cytokine, particularly TNF-α and IL-1β prodn.  SAR will be discussed regarding activity at the enzyme target, but also with regard to properties required for efficient in vitro and in vivo activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxT_2yIMHnHbVg90H21EOLACvtfcHk0lhc6cUhOn6RLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVantrs%253D&md5=584981b91cea4f35a7ffdef80b8b31b2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F156802606775270323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606775270323%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DNew%2520approaches%2520to%2520the%2520treatment%2520of%2520inflammatory%2520disorders%2520small%2520molecules%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%2520%2528Review%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D113%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, T.</span><span> </span><span class="NLM_article-title">Pathway to the clinic: Inhibition of p38 MAP kinase. A review of ten chemotypes selected for development (Review)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.2174%2F1568026054985939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16178744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1017-1029&author=D.+M.+Goldsteinauthor=T.+Gabriel&title=Pathway+to+the+clinic%3A+Inhibition+of+p38+MAP+kinase.+A+review+of+ten+chemotypes+selected+for+development+%28Review%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathway to the clinic: Inhibition of P38 MAP kinase. A review of ten chemotypes selected for development</span></div><div class="casAuthors">Goldstein, David M.; Gabriel, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 mitogen activated protein (MAP) kinase remains the most compelling therapeutic target for oral drug intervention for a wide range of autoimmune disorders based on the central role this enzyme plays in inflammatory cell signaling.  Efforts to discover inhibitors of p38 suitable for clin. investigation have continued to escalate in part due to the incredible diversity of unique chemotypes reported to inhibit the enzyme.  Since 1993, at least seventeen p38 inhibitors have been reported to have entered into clin. trials.  Next generation inhibitors have been disclosed with improved potency for p38 and enhanced selectivity vs. other protein kinases.  Over the last three years, there have been multiple reports of cytokine suppression in humans following oral administration of p38 inhibitors.  These results, in addn. to proof of concept studies in rheumatoid patients, have established p38 inhibition as an avenue for the future management of pro-inflammatory cytokine based diseases.  This review describes the discovery at Roche of novel p38 inhibitors which have advanced into clin. trials.  The pharmacol. of the Roche compds. is then compared with eight chem. distinct p38 inhibitors known to have entered clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrve3HIFcxtSrVg90H21EOLACvtfcHk0lhkSf0q5zZ4Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeitrbK&md5=a4acd0c62b42c1f2eb4dafd8f8b60306</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026054985939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054985939%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DT.%26atitle%3DPathway%2520to%2520the%2520clinic%253A%2520Inhibition%2520of%2520p38%2520MAP%2520kinase.%2520A%2520review%2520of%2520ten%2520chemotypes%2520selected%2520for%2520development%2520%2528Review%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1017%26epage%3D1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braganza, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuperman, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLiberte, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peese, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeny, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trebino, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volberg, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4339-4344&issue=16&author=K.+F.+McClureauthor=M.+A.+Letavicauthor=A.+S.+Kalgutkarauthor=C.+A.+Gabelauthor=L.+Audolyauthor=J.+T.+Barberiaauthor=J.+F.+Braganzaauthor=D.+Carterauthor=T.+J.+Cartyauthor=S.+R.+Cortinaauthor=M.+A.+Dombroskiauthor=K.+M.+Donahueauthor=N.+C.+Elliottauthor=C.+P.+Gibbonsauthor=C.+K.+Jordanauthor=A.+V.+Kupermanauthor=J.+M.+Labasiauthor=R.+E.+LaLiberteauthor=J.+M.+McCoyauthor=B.+M.+Naimanauthor=K.+L.+Nelsonauthor=H.+T.+Nguyenauthor=K.+M.+Peeseauthor=F.+J.+Sweenyauthor=T.+J.+Taylorauthor=C.+E.+Trebinoauthor=Y.+A.+Abramovauthor=E.+R.+Lairdauthor=W.+A.+Volbergauthor=J.+Zhouauthor=J.+Bachauthor=F.+Lombardo&title=Structure%E2%88%92activity+relationships+of+triazolopyridine+oxazole+p38+inhibitors%3A+identification+of+candidates+for+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DBarberia%26aufirst%3DJ.%2BT.%26aulast%3DBraganza%26aufirst%3DJ.%2BF.%26aulast%3DCarter%26aufirst%3DD.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DElliott%26aufirst%3DN.%2BC.%26aulast%3DGibbons%26aufirst%3DC.%2BP.%26aulast%3DJordan%26aufirst%3DC.%2BK.%26aulast%3DKuperman%26aufirst%3DA.%2BV.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DLaLiberte%26aufirst%3DR.%2BE.%26aulast%3DMcCoy%26aufirst%3DJ.%2BM.%26aulast%3DNaiman%26aufirst%3DB.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DSweeny%26aufirst%3DF.%2BJ.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrebino%26aufirst%3DC.%2BE.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DVolberg%26aufirst%3DW.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DBach%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520triazolopyridine%2520oxazole%2520p38%2520inhibitors%253A%2520identification%2520of%2520candidates%2520for%2520clinical%2520development%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D16%26spage%3D4339%26epage%3D4344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Natarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-<i>d</i>]pyrimidones and 3,4-dihydropyrido[4,3-<i>d</i>]pyrimidin-2-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">4400</span><span class="NLM_x">–</span> <span class="NLM_lpage">4404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4400-4404&issue=16&author=S.+R.+Natarajanauthor=D.+D.+Wisnoskiauthor=J.+E.+Thompsonauthor=E.+A.+O%E2%80%99Neillauthor=S.+J.+O%E2%80%99Keefe&title=p38+MAP+kinase+inhibitors.+Part+3%3A+SAR+on+3%2C4-dihydropyrimido%5B4%2C5-d%5Dpyrimidones+and+3%2C4-dihydropyrido%5B4%2C3-d%5Dpyrimidin-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNatarajan%26aufirst%3DS.%2BR.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors.%2520Part%25203%253A%2520SAR%2520on%25203%252C4-dihydropyrimido%255B4%252C5-d%255Dpyrimidones%2520and%25203%252C4-dihydropyrido%255B4%252C3-d%255Dpyrimidin-2-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26issue%3D16%26spage%3D4400%26epage%3D4404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Dominguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, N.</span><span> </span><span class="NLM_article-title">p38 MAP kinase inhibitors: Many are made, but few are chosen</span> <span class="citation_source-journal">Curr. Opin. Drug Dis. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16022178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=421-430&issue=4&author=C.+Dominguezauthor=D.+A.+Powersauthor=N.+Tamayo&title=p38+MAP+kinase+inhibitors%3A+Many+are+made%2C+but+few+are+chosen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">p38 MAP kinase inhibitors: Many are made, but few are chosen</span></div><div class="casAuthors">Dominguez, Celia; Powers, David A.; Tamayo, Nuria</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The mitogen-activated protein kinase (MAPK) p38 is a Ser/Thr kinase, originally isolated from lipopolysaccharide-stimulated monocytes.  There are 4 isoforms of the enzyme (p38α, p38β, p38γ and p38δ), which differ in tissue distribution, regulation of kinase activation, and subsequent phosphorylation of downstream substrates.  These enzymes also differ in sensitivity to p38 MAPK inhibitors.  The most thoroughly studied isoform is p38α, for which activation was obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  P38α kinase is involved in the biosynthesis of the cytokines tumor necrosis factor-α and interleukin-1β at the translational and transcriptional level.  MAPK p38α represents a point of convergence for multiple signaling processes that are activated during inflammation, making it a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and a pyridinyl-imidazole-based p38α inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatments for inflammatory diseases.  Herein, a brief overview is provided of the discovery and development of AMG-548 (Amgen Inc), a selective and efficacious p38α inhibitor, and its pharmacodynamic effects in a 1st-in-human study.  Data from a phase I multidose clin. trial are also included.  In addn., other p38α inhibitors that have advanced to clin. trials over the last 3 years are discussed, such as BIRB-796 (Boehringer Ingelheim Pharmaceuticals Inc).  SCIO-469 and SCIO-323 (Scios Inc), and VX-702 (Vertex Pharmaceuticals Inc/Kissei Pharmaceutical Co).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjiFXW2ScCerVg90H21EOLACvtfcHk0lhkSf0q5zZ4Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFCgt7s%253D&md5=d07c0471bc8e02479c0fdd710bfdbb69</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DPowers%26aufirst%3DD.%2BA.%26aulast%3DTamayo%26aufirst%3DN.%26atitle%3Dp38%2520MAP%2520kinase%2520inhibitors%253A%2520Many%2520are%2520made%252C%2520but%2520few%2520are%2520chosen%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Dis.%2520Dev.%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, C.</span><span> </span><span class="NLM_article-title">MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38α protein</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2979</span><span class="NLM_x">–</span> <span class="NLM_lpage">2994</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.2174%2F092986705774462914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=16378500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2979-2994&author=M.+R.+Leeauthor=C.+Dominguez&title=MAP+kinase+p38+inhibitors%3A+clinical+results+and+an+intimate+look+at+their+interactions+with+p38%CE%B1+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MAP kinase p38 inhibitors: Clinical results and an intimate look at their interactions with p38α protein</span></div><div class="casAuthors">Lee, Matthew R.; Dominguez, Celia</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2979-2994</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mitogen-activated protein kinase p38 is a serine/threonine kinase originally isolated from lipopolysaccharide (LPS) stimulated monocytes.  There are four isoforms p38α, p38β, p38γ, and p38δ.  The most thoroughly studied isoform is p38α, whose activation has been obsd. in many hematopoietic and non-hematopoietic cell types upon appropriate stimuli.  Subsequently, p38α kinase has been shown to be involved in the biosynthesis of TNFα and IL-1β at the translational and transcriptional level.  MAP kinase p38α represents a point of convergence for multiple signaling processes that are activated in inflammation and thus a key potential target for the modulation of cytokine prodn.  The discovery and publication of p38α and the pyridinyl-imidazole inhibitor initiated a huge effort by many companies to develop p38α inhibitors as potential treatment for inflammatory diseases.  Herein we provide a brief overview of recent reported clin. results for AMG 548, BIRB 796, VX 702, SCIO 469, and SCIO 323.  However, our focus will be on the binding modes of these inhibitors and other p38 inhibitors in the recent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZSldsfUAO6bVg90H21EOLACvtfcHk0li1eoyg52g7sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Grt7jF&md5=eb21253fcc2df76280cd9a1812ed1015</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F092986705774462914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774462914%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DDominguez%26aufirst%3DC.%26atitle%3DMAP%2520kinase%2520p38%2520inhibitors%253A%2520clinical%2520results%2520and%2520an%2520intimate%2520look%2520at%2520their%2520interactions%2520with%2520p38%25CE%25B1%2520protein%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2979%26epage%3D2994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors: discovery and binding mode</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=318-323&issue=1&author=R.+M.+Angellauthor=P.+Bamboroughauthor=A.+Cleasbyauthor=S.+G.+Cockerillauthor=K.+L.+Jonesauthor=C.+J.+Mooneyauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors%3A+discovery+and+binding+mode"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DMooney%26aufirst%3DC.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%253A%2520discovery%2520and%2520binding%2520mode%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D318%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, M.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors. 2: Optimization and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=324-328&issue=1&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=D.+Brownauthor=M.+Brownauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=C.+D.+Edwardsauthor=K.+L.+Jonesauthor=T.+Longstaffauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=M.+Willson&title=Biphenyl+amide+p38+kinase+inhibitors.+2%3A+Optimization+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWillson%26aufirst%3DM.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors.%25202%253A%2520Optimization%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D1%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Boeck, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors. 3: Improvement of cellular and in vivo activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4428</span><span class="NLM_x">–</span> <span class="NLM_lpage">4432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4428-4432&issue=15&author=R.+M.+Angellauthor=N.+M.+Astonauthor=P.+Bamboroughauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=S.+J.+de+Boeckauthor=C.+D.+Edwardsauthor=D.+S.+Holmesauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=S.+Patelauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors.+3%3A+Improvement+of+cellular+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAston%26aufirst%3DN.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3Dde%2BBoeck%26aufirst%3DS.%2BJ.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors.%25203%253A%2520Improvement%2520of%2520cellular%2520and%2520in%2520vivo%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4428%26epage%3D4432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludbrook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide 38 kinase inhibitors. 4: DFG-in and DFG-out binding modes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4433-4437&issue=15&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=M.+J.+Bamfordauthor=C.+Chungauthor=S.+G.+Cockerillauthor=S.+S.+Flackauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=T.+Longstaffauthor=S.+Ludbrookauthor=R.+Pearsonauthor=K.+J.+Smithauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+38+kinase+inhibitors.+4%3A+DFG-in+and+DFG-out+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DFlack%26aufirst%3DS.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DLudbrook%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%252038%2520kinase%2520inhibitors.%25204%253A%2520DFG-in%2520and%2520DFG-out%2520binding%2520modes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D15%26spage%3D4433%26epage%3D4437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Schrier, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flory, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, D.K-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. A.</span><span> </span><span class="NLM_article-title">Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=9500524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK1cXhs1OqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=359-363&author=D.+C.+Schrierauthor=R.+C.+Schimmerauthor=C.+M.+Floryauthor=D.K-L.+Tungauthor=P.+A.+Ward&title=Role+of+chemokines+and+cytokines+in+a+reactivation+model+of+arthritis+in+rats+induced+by+injection+with+streptococcal+cell+walls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls</span></div><div class="casAuthors">Schrier, D. J.; Schimmer, R. C.; Flory, C. M.; Tung, D. K. - L.; Ward, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-363</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Intra-articular injection of streptococcal cell wall (SCW) antigen followed by i.v. challenge results in a T cell-mediated monoarticular arthritis in female Lewis rats.  Initial studies showed that this reactivation response to i.v. SCW antigen is dependent on the presence of interleukin-1 (IL-1) and tumor necrosis factor α (TNF-α) and that the early phase of swelling is neutrophil-dependent.  Neutrophil depletion or passive immunization with antibodies to P-selectin or macrophage inflammatory protein-2 reduced the intensity of ankle edema and the influx of neutrophils.  After the first few days, however, the arthritic response is mediated primarily by mononuclear cells.  Joint tissues showed up-regulation of mRNA for monocyte chemotactic protein-1 (MCP-1), which could be inhibited in part by anti-IL-4; treatment of rats with antibodies to IL-4 or MCP-1 significantly suppressed development of ankle edema and histopathol. evidence of inflammation.  Antibodies to interferon-γ or IL-10 had no effect.  Treatment with anti-MCP-1 also suppressed influx of 111In-labeled T cells into the ankle joint.  These data suggest that the late, mononuclear-dependent phase of SCW-induced arthritis in female Lewis rats requires cytokines that up-regulate MCP-1, which in turn may facilitate recruitment and extravasation of mononuclear cells into the joint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVmkq5PnxGrVg90H21EOLACvtfcHk0li9g1jl7MEm6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs1OqtLg%253D&md5=08f0f15db0d46f7372c745b0f7797967</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchrier%26aufirst%3DD.%2BC.%26aulast%3DSchimmer%26aufirst%3DR.%2BC.%26aulast%3DFlory%26aufirst%3DC.%2BM.%26aulast%3DTung%26aufirst%3DD.K-L.%26aulast%3DWard%26aufirst%3DP.%2BA.%26atitle%3DRole%2520of%2520chemokines%2520and%2520cytokines%2520in%2520a%2520reactivation%2520model%2520of%2520arthritis%2520in%2520rats%2520induced%2520by%2520injection%2520with%2520streptococcal%2520cell%2520walls%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1998%26volume%3D63%26spage%3D359%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Courtenay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayan, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosedale, B.</span><span> </span><span class="NLM_article-title">Immunisation against heterologous type II collagen-induced arthritis in mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">2843</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2843&publication_year=1980&pages=666-668&author=J.+S.+Courtenayauthor=M.+J.+Dallmanauthor=A.+B.+Dayanauthor=A.+Martinauthor=B.+Mosedale&title=Immunisation+against+heterologous+type+II+collagen-induced+arthritis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCourtenay%26aufirst%3DJ.%2BS.%26aulast%3DDallman%26aufirst%3DM.%2BJ.%26aulast%3DDayan%26aufirst%3DA.%2BB.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DMosedale%26aufirst%3DB.%26atitle%3DImmunisation%2520against%2520heterologous%2520type%2520II%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DNature%26date%3D1980%26volume%3D2843%26spage%3D666%26epage%3D668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Joosten, L. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsen, M. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Loo, F. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, W. B.</span><span> </span><span class="NLM_article-title">Anticytokine treatment of established collagen-induced arthritis in DBA/1 mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1002%2Fart.1780390513" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=8639177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK28XjsValtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=797-809&author=L.+A.+B.+Joostenauthor=M.+M.+A.+Helsenauthor=F.+A.+J.+van+de+Looauthor=W.+B.+van+den+Berg&title=Anticytokine+treatment+of+established+collagen-induced+arthritis+in+DBA%2F1+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra</span></div><div class="casAuthors">Joosten, Leo A. B.; Helsen, Monique M. A.; Van De Loo, Fons A. J.; Van Den Berg, Wim B.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">797-809</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven</span>)
        </div><div class="casAbstract">The authors examd. the role of tumor necrosis factor α (TNF α), interleukin-1α (IL-1α), and IL-1β in collagen-induced arthritis (CIA), immediately after onset and during the phase of established arthritis.  Male DBA/1 mice with collagen-induced arthritis were treated with antibodies against murine TNF α and IL-1α/β at different time points of the disease.  IL-1 receptor antagonist (IL-1Ra) was administered using Alzet osmotic mini-pumps.  The effect of anti-cytokine treatment was monitored by visual scoring.  Histol. and cytokine reverse transcription polymerase chain reaction (RT-PCR) analyses were performed at the end of the treatment period.  Anti-TNF α treatment showed efficacy shortly after onset of the disease, but had little effect on fully established CIA.  Histol. anal. after early treatment revealed that anti-TNF α significantly reduced joint pathol., as detd. by infiltration of inflammatory cells and cartilage damage.  Anti-IL-1α/β treatment ameliorated both early and full-blown CIA.  This clear suppression of established arthritis was confirmed by administration of high doses of IL-1Ra.  Dose-response expts. showed that a continuous supply of 1 mg/day was needed for optimal suppression.  Histol. anal. showed markedly reduced cartilage destruction both in the knee and the ankle joints.  Autoradiog. demonstrated full recovery of chondrocyte synthetic function of articular cartilage.  In addn., the authors found that the IL-1β isoform plays a dominant role in established CIA.  Profound suppression of CIA was obsd. with anti-IL-1β, although elimination of both IL-1α and IL-1β still gave better protection.  Anal. of mRNA with RT-PCR revealed that IL-1β was highly upregulated in synovium and cartilage at late stages of CIA, whereas anti-IL-1β treatment markedly reduced IL-1β message in the synovium.  The present study identified different TNFα/IL-1 dependencies in various stages of CIA and revealed that blocking of TNFα does not necessarily eliminate IL-1.  Continuous, high doses of IL-1Ra are needed to block CIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPs5rv07Iyo7Vg90H21EOLACvtfcHk0li9g1jl7MEm6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsValtLc%253D&md5=cb86f131237c1b630e0d039215f52d72</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fart.1780390513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780390513%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DHelsen%26aufirst%3DM.%2BM.%2BA.%26aulast%3Dvan%2Bde%2BLoo%26aufirst%3DF.%2BA.%2BJ.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%2BB.%26atitle%3DAnticytokine%2520treatment%2520of%2520established%2520collagen-induced%2520arthritis%2520in%2520DBA%252F1%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D1996%26volume%3D39%26spage%3D797%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Joosten, L. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helsen, M. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Loo, F. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinegard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, W. B.</span><span> </span><span class="NLM_article-title">IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen induced arthritis whereas TNF-α blockade only ameliorates joint inflammation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">5049</span><span class="NLM_x">–</span> <span class="NLM_lpage">5055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=5049-5055&author=L.+A.+B.+Joostenauthor=M.+M.+A.+Helsenauthor=T.+Saxneauthor=F.+A.+J.+van+de+Looauthor=D.+Heinegardauthor=W.+B.+van+den+Berg&title=IL-1%CE%B1%CE%B2+blockade+prevents+cartilage+and+bone+destruction+in+murine+type+II+collagen+induced+arthritis+whereas+TNF-%CE%B1+blockade+only+ameliorates+joint+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DHelsen%26aufirst%3DM.%2BM.%2BA.%26aulast%3DSaxne%26aufirst%3DT.%26aulast%3Dvan%2Bde%2BLoo%26aufirst%3DF.%2BA.%2BJ.%26aulast%3DHeinegard%26aufirst%3DD.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DW.%2BB.%26atitle%3DIL-1%25CE%25B1%25CE%25B2%2520blockade%2520prevents%2520cartilage%2520and%2520bone%2520destruction%2520in%2520murine%2520type%2520II%2520collagen%2520induced%2520arthritis%2520whereas%2520TNF-%25CE%25B1%2520blockade%2520only%2520ameliorates%2520joint%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D5049%26epage%3D5055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Williams, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, R. N.</span><span> </span><span class="NLM_article-title">Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">9784</span><span class="NLM_x">–</span> <span class="NLM_lpage">9788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=9784-9788&author=R.+O.+Williamsauthor=M.+Feldmannauthor=R.+N.+Maini&title=Anti-tumor+necrosis+factor+ameliorates+joint+disease+in+murine+collagen-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DMaini%26aufirst%3DR.%2BN.%26atitle%3DAnti-tumor%2520necrosis%2520factor%2520ameliorates%2520joint%2520disease%2520in%2520murine%2520collagen-induced%2520arthritis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1992%26volume%3D89%26spage%3D9784%26epage%3D9788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D.</span><span> </span><span class="NLM_article-title">Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC: A High-Throughput Alternative to Log P/log D</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2022</span><span class="NLM_x">–</span> <span class="NLM_lpage">2029</span></span><div class="citationLinks">[<a href="/doi/10.1021/ac961242d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=2022-2029&issue=11&author=K.+Valkoauthor=C.+Bevanauthor=D.+Reynolds&title=Chromatographic+Hydrophobicity+Index+by+Fast-Gradient+RP-HPLC%3A+A+High-Throughput+Alternative+to+Log+P%2Flog+D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fac961242d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac961242d%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DChromatographic%2520Hydrophobicity%2520Index%2520by%2520Fast-Gradient%2520RP-HPLC%253A%2520A%2520High-Throughput%2520Alternative%2520to%2520Log%2520P%252Flog%2520D%26jtitle%3DAnal.%2520Chem.%26date%3D1997%26volume%3D69%26issue%3D11%26spage%3D2022%26epage%3D2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">HSA binding constants were obtained by high performance affinity chromatography on a column of immobilized human serum albumin.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Solubilities were measured either from dissolution of solid into water buffered to pH7.4 or by precipitation from 10 mM DMSO solution.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Edwards, C. D.</span><div class="note"><p class="first last">Drug Metabolism Discussion Group, Sept 2004. Poster included in <a class="ref internalNav" href="#si" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Edwards%2C+C.+D.Drug+Metabolism+Discussion+Group%2C+Sept+2004.+Poster+included+in+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DC.%2BD." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Okada, S.; Kayakiri, N.; Sawaday, Y.; Tanaka, H.; Hashimoto, M.</span><span> </span><span class="NLM_article-title">Indole derivatives</span>. World Patent WO93/03012,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=S.+Okada&author=N.+Kayakiri&author=Y.+Sawaday&author=H.+Tanaka&author=M.+Hashimoto&title=Indole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DS.%26atitle%3DIndole%2520derivatives%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Schlosser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geneste, H.</span><span> </span><span class="NLM_article-title">The super base approach to flurbiprofen: an exercise in optionally site-selective metalation</span> <span class="citation_source-journal">Chem.—Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1969</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1002%2F%28SICI%291521-3765%2819981002%294%3A10%3C1969%3A%3AAID-CHEM1969%3E3.0.CO%3B2-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm9004779&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVOmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1969-1973&issue=10&author=M.+Schlosserauthor=H.+Geneste&title=The+super+base+approach+to+flurbiprofen%3A+an+exercise+in+optionally+site-selective+metalation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The super base approach to flurbiprofen: an exercise in optionally site-selective metalation</span></div><div class="casAuthors">Schlosser, Manfred; Geneste, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry--A European Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1969-1973</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A superior route to the analgesic flurbiprofen has been devised.  Key steps are the selective deprotonation of 3-fluorotoluene with tert-butyllithium in the presence of potassium tert-butoxide (LIT-KOR) at the 4-position and the selective deprotonation of the 4-methyl-2-fluorobiphenyl with lithium diisopropylamide in the presence of potassium tert-butoxide (LIDA-KOR) at the benzylic position.  Depending on the reagent and the substituent pattern, the 3- and 5-positions of 2-fluorobiphenyls can also be specifically attacked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDD_bH5W5xXrVg90H21EOLACvtfcHk0lj-n8IMA35_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVOmt7g%253D&md5=b1166369fe27e66e51b3a5bd14203c89</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3765%2819981002%294%3A10%3C1969%3A%3AAID-CHEM1969%3E3.0.CO%3B2-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3765%252819981002%25294%253A10%253C1969%253A%253AAID-CHEM1969%253E3.0.CO%253B2-O%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosser%26aufirst%3DM.%26aulast%3DGeneste%26aufirst%3DH.%26atitle%3DThe%2520super%2520base%2520approach%2520to%2520flurbiprofen%253A%2520an%2520exercise%2520in%2520optionally%2520site-selective%2520metalation%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D1998%26volume%3D4%26issue%3D10%26spage%3D1969%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span>.  <span class="citation_source-book">Macromolecular Crystallography, Part A</span>; <span class="NLM_series">Methods in Enzymology, Vol. 276</span>; <span class="NLM_contrib-group">Carter, C.W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.W.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%26aulast%3DCarter%26aufirst%3DC.W.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Collaborative Computational Project Number 4</span><span> </span><span class="NLM_article-title">The CCP4 Suite: Programs for Protein Crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm9004779&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm9004779&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&issue=5&author=Collaborative+Computational+Project+Number+4&title=The+CCP4+Suite%3A+Programs+for+Protein+Crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520Suite%253A%2520Programs%2520for%2520Protein%2520Crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26issue%3D5%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&issue=5&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26issue%3D5%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1WFC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1WFC','PDB','1WFC'); return false;">PDB: 1WFC</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a href="/doi/suppl/10.1021/jm9004779">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22251"></div></div></div></div></div><hr /></hr><p class="last">NMR spectrum for compound <b>2</b>, pharmacokinetic protocols for rat cassette, rat discrete, and cynomolgus monkey studies, rat PG-PS model protocol, murine CIA protocol, poster giving further information about modeling used in generation of virtual arrays. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9004779/suppl_file/jm9004779_si_001.pdf">jm9004779_si_001.pdf (208.05 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9004779&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-20%3Barticle%3Aarticle%3A10.1021%2Fjm9004779%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9004779" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677af97a4a8e2290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
